<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84710</article-id><article-id pub-id-type="doi">10.7554/eLife.84710</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Mitochondrial defects caused by PARL deficiency lead to arrested spermatogenesis and ferroptosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Radaelli</surname><given-names>Enrico</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2885-0221</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Assenmacher</surname><given-names>Charles-Antoine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Verrelle</surname><given-names>Jillian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Banerjee</surname><given-names>Esha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Manero</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Khiati</surname><given-names>Salim</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Girona</surname><given-names>Anais</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lopez-Lluch</surname><given-names>Guillermo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Navas</surname><given-names>Placido</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Spinazzi</surname><given-names>Marco</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0048-9558</contrib-id><email>marco.spinazzi@chu-angers.fr</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Pathobiology, Comparative Pathology Core, School of Veterinary Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yrqp957</institution-id><institution>University of Angers</institution></institution-wrap><addr-line><named-content content-type="city">Angers</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yrqp957</institution-id><institution>Unité Mixte de Recherche (UMR) MITOVASC, Centre National de la Recherche Scientifique (CNRS) 6015, Institut National de la Santé et de la Recherche Médicale (INSERM) U1083, University of Angers</institution></institution-wrap><addr-line><named-content content-type="city">Angers</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01v5e3436</institution-id><institution>Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-Consejo Superior de Investigaciones Científicas-Junta de Andalucía</institution></institution-wrap><addr-line><named-content content-type="city">Sevilla</named-content></addr-line><country>Spain</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ca2c886</institution-id><institution>CIBERER, Instituto de Salud Carlos III</institution></institution-wrap><addr-line><named-content content-type="city">Madrid</named-content></addr-line><country>Spain</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0250ngj72</institution-id><institution>Neuromuscular Reference Center, Department of Neurology, CHU Angers</institution></institution-wrap><addr-line><named-content content-type="city">Angers</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>07</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e84710</elocation-id><history><date date-type="received" iso-8601-date="2022-11-05"><day>05</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-07-23"><day>23</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-11-22"><day>22</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.22.517461"/></event></pub-history><permissions><copyright-statement>© 2023, Radaelli et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Radaelli et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84710-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-84710-figures-v3.pdf"/><abstract><p>Impaired spermatogenesis and male infertility are common manifestations associated with mitochondrial diseases, yet the underlying mechanisms linking these conditions remain elusive. In this study, we demonstrate that mice deficient for the mitochondrial intra-membrane rhomboid protease PARL, a recently reported model of the mitochondrial encephalopathy Leigh syndrome, develop early testicular atrophy caused by a complete arrest of spermatogenesis during meiotic prophase I, followed by degeneration and death of arrested spermatocytes. This process is independent of neurodegeneration. Interestingly, genetic modifications of PINK1, PGAM5, and TTC19 – three major substrates of PARL with important roles in mitochondrial homeostasis – fail to reproduce or modify this severe phenotype, indicating that the spermatogenic arrest arises from distinct molecular pathways. We further observed severe abnormalities in mitochondrial ultrastructure in PARL-deficient spermatocytes, along with prominent electron transfer chain defects, disrupted coenzyme Q (CoQ) biosynthesis, and metabolic rewiring. These mitochondrial defects are associated with a germ cell-specific decrease in GPX4 expression leading arrested spermatocytes to ferroptosis – a regulated cell death modality characterized by uncontrolled lipid peroxidation. Our results suggest that mitochondrial defects induced by PARL depletion act as an initiating trigger for ferroptosis in primary spermatocytes through simultaneous effects on GPX4 and CoQ – two major inhibitors of ferroptosis. These findings shed new light on the potential role of ferroptosis in the pathogenesis of mitochondrial diseases and male infertility warranting further investigation.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Up to 9% of men are thought to experience infertility. These individuals may not produce enough healthy sperm cells. The root cause of infertility is often not discovered but, in some cases, it is associated with genetic defects in cell compartments known as mitochondria.</p><p>Mitochondria are responsible for converting energy from food into a form of chemical energy cells need to power vital processes. However, it remains unclear how defects in mitochondria contribute to male infertility.</p><p>Leigh syndrome is one of the most prevalent and severe diseases caused by genetic defects in mitochondria. The condition often develops in childhood and affects the nervous system, muscle and other organs, leading to many symptoms including muscle weakness and neurological regression. A previous study found that mutant mice that lack an enzyme, called PARL, display symptoms that are similar to those observed in humans with Leigh syndrome. PARL is found inside mitochondria where it cuts specific proteins to ensure they are working correctly in the cells.</p><p>Radaelli et al. used extensive microscopy and biochemical analyses to study the fertility of male mice lacking PARL. The experiments revealed that the males were infertile due to a failure to produce sperm: spermatocytes, which usually develop into sperm cells, where much more likely to die in mice without PARL (by a process known as ferroptosis).</p><p>Further experiments demonstrated that the mitochondria of the mutant mice had a shortage of two crucial molecules, a protein called GPX4 and a lipid called Coenzyme Q, which are required to prevent death by ferroptosis. It appears that this shortage was responsible for the demise of spermatocytes in the male mutant mice affected by infertility.</p><p>These findings reveal a new role for PARL in the body and provide evidence that mitochondrial defects in living mammals can trigger ferroptosis, thereby contributing to male infertility. In the future, this research may pave the way for new treatments for male infertility and other diseases associated with defects in mitochondria.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>PARL</kwd><kwd>ferroptosis</kwd><kwd>GPX4</kwd><kwd>coenzyme Q</kwd><kwd>spermatogenesis</kwd><kwd>mitochondria</kwd><kwd>respiratory chain</kwd><kwd>mitochondrial structure</kwd><kwd>Leigh syndrome</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006920</institution-id><institution>University of Pennsylvania</institution></institution-wrap></funding-source><award-id>URF Fall 19-0914</award-id><principal-award-recipient><name><surname>Radaelli</surname><given-names>Enrico</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004923</institution-id><institution>Association Française Myopathies (AFM) Telethon</institution></institution-wrap></funding-source><award-id>23019</award-id><principal-award-recipient><name><surname>Spinazzi</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100017006</institution-id><institution>Abramson Cancer Center</institution></institution-wrap></funding-source><award-id>P30CA016520</award-id><principal-award-recipient><name><surname>Radaelli</surname><given-names>Enrico</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mitochondrial functional and structural defects caused by PARL deficiency lead to arrested spermatogenesis and germ cell ferroptosis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Impaired spermatogenesis and consequent infertility are increasingly prevalent medical concerns affecting approximately 9% of the global male population (<xref ref-type="bibr" rid="bib10">Boivin et al., 2009</xref>). The underlying mechanisms of these conditions appear to involve oxidative stress and mitochondrial dysfunction, but their specific contribution is poorly characterized (<xref ref-type="bibr" rid="bib4">Aitken et al., 2022</xref>). Furthermore, male infertility has been identified as a significant manifestation of mitochondrial diseases (<xref ref-type="bibr" rid="bib57">Martikainen et al., 2017</xref>). While the essential roles of mitochondria in reproductive biology, including spermatogenesis, are established, their precise mechanisms remain incompletely understood (<xref ref-type="bibr" rid="bib14">Cannon et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Rajender et al., 2010</xref>). Mitochondrial diseases encompass a range of inborn errors of metabolism caused by genetic defects in either mitochondrial or nuclear genome. The selective vulnerability of specific organs or tissues to these genetic defects remains an enigma and is likely influenced by cell-type-specific activation of poorly understood downstream molecular pathways acting independently of or in parallel with mitochondrial respiratory chain defects. Notably, energy insufficiency alone cannot fully explain the extremely heterogenous clinical manifestations observed (<xref ref-type="bibr" rid="bib22">Dogan et al., 2014</xref>). Consequently, complex molecular responses to mitochondrial dysfunction are gaining recognition as crucial pathogenetic mechanisms (<xref ref-type="bibr" rid="bib84">Suomalainen and Battersby, 2018</xref>; <xref ref-type="bibr" rid="bib44">Khan et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Forsström et al., 2019</xref>).</p><p>In our previous study, we described PARL-deficient mice as a novel model of mitochondrial encephalopathy resembling Leigh syndrome (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>), one of the most common and severe mitochondrial diseases. PARL, an evolutionary conserved protease belonging to the rhomboid family, is located in the inner mitochondrial membrane and has fundamental roles in cell homeostasis. PARL has been associated with various human disorders such as Parkinson’s disease, Leber hereditary optic neuropathy, and type 2 diabetes, albeit with some controversy (<xref ref-type="bibr" rid="bib76">Shi et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Hatunic et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Istikharah et al., 2013</xref>; <xref ref-type="bibr" rid="bib79">Spinazzi and De Strooper, 2016</xref>). Notably, PARL’s significant role in maintaining mitochondrial fitness has been established through critical studies that identified its substrates, such as PINK1 (<xref ref-type="bibr" rid="bib43">Jin et al., 2010</xref>), a mitochondrial kinase implicated in Parkinson’s disease and mitophagy (<xref ref-type="bibr" rid="bib89">Valente et al., 2004</xref>; <xref ref-type="bibr" rid="bib97">Yan et al., 2020</xref>), PGAM5 (<xref ref-type="bibr" rid="bib75">Sekine et al., 2012</xref>), a mitochondrial phosphatase implicated in Parkinsonism in mice (<xref ref-type="bibr" rid="bib52">Lu et al., 2014</xref>), and TTC19 (<xref ref-type="bibr" rid="bib69">Saita et al., 2017</xref>), a mitochondrial protein involved in maintaining complex III activity and associated with human Leigh syndrome (<xref ref-type="bibr" rid="bib11">Bottani et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Atwal, 2014</xref>).</p><p>In this study, we focus on impaired spermatogenesis as the earliest phenotype observed in PARL-deficient male mice, which occurs independently of neurodegeneration. We find that PARL deficiency leads to severe functional and structural abnormalities in germ cell mitochondria, resulting in a complete arrest of spermatogenesis and triggering ferroptosis specifically in spermatocytes. Our findings offer new insights into the role of mitochondrial dysfunction and ferroptosis in male infertility and pave the way for further investigations on this cell death mechanism in mitochondrial diseases.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>PARL deficiency results in arrested spermatogenesis and severe testis atrophy</title><p>PARL-deficient mice appear clinically normal until around 6 weeks of age, after which they develop a progressive necrotizing encephalomyelopathy resembling Leigh syndrome with death before the age of 8 weeks (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). As previously described, these mice exhibit severe testis atrophy (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>; <xref ref-type="bibr" rid="bib17">Cipolat et al., 2006</xref>). We did not observe cryptorchidism. Upon closer examination, the testis weight of <italic>Parl<sup>-/-</sup></italic> mice at 5 weeks of age, when they do not show clinical signs of neurological impairment, is found to be nearly half of that in matched WT littermates (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). This difference cannot be explained by concurrent body weight reduction (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Microscopic analysis reveals that the seminiferous tubules from <italic>Parl<sup>-/-</sup></italic> mice are smaller in diameter (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; p=0.0002, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and contain approximately 40% fewer cells compared to WT littermates (p=0.0009, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Further investigation indicates that the seminiferous tubules in <italic>Parl<sup>-/-</sup></italic> mice are populated by immature germ cells exhibiting degenerative changes and prominent intraluminal exfoliation, often in the form of multinucleated syncytia (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Immunohistochemistry reveals that PARL deficiency leads to a complete meiotic prophase I arrest as the seminiferous tubules are predominantly populated by SCP-1-positive spermatocytes (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>; <xref ref-type="bibr" rid="bib98">Yang and Wang, 2009</xref>; p=0.0001) while spermatids and spermatozoa are completely absent (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib45">Köhler, 2007</xref>). The epididymal ducts of <italic>Parl<sup>-/-</sup></italic> mice are also smaller in diameter and completely devoid of mature sperm (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Spermatogonia show a modest increase in number in <italic>Parl<sup>-/-</sup></italic> seminiferous tubules compared to WT littermates (p=0.01; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Additionally, the analysis of γH2AX expression pattern in <italic>Parl<sup>-/-</sup></italic> seminiferous tubules indicates specific meiotic prophase I arrest at the pachytene stage (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). Supporting Sertoli cells appear to be slightly increased in number (p=0.0382; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E and F</xref>), and the distribution and morphology of Leydig cells appears normal.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Severe testis atrophy in <italic>Parl<sup>-/-</sup></italic> mice is caused by arrested spermatogenesis.</title><p>(<bold>A</bold>) Reduced testicular size and weight in 5-week-old <italic>Parl<sup>-/-</sup></italic> mice (n = 5) compared to WT littermates (n = 6; unpaired two-tailed <italic>t</italic>-test, p-value&lt;0.0001). The reduction in testicular weight is not explained by body weight differences (p=0.0598). (<bold>B</bold>) Histological assessment of testes from 6-week-old <italic>Parl<sup>-/-</sup></italic> and WT mice reveals reduced diameter of <italic>Parl<sup>-/-</sup></italic> seminiferous tubules with impaired germ cell maturation and complete spermatogenesis arrest at the level of primary spermatocytes (testis HE stain, n = 10 for each genotype). <italic>Parl<sup>-/-</sup></italic> seminiferous tubules also exhibit intraluminal exfoliation of degenerated spermatocytes often in the form of multinucleated syncytia (testis HE stain inset, arrowheads). The complete arrest of spermatogenesis leads to total absence of sperm in <italic>Parl<sup>-/-</sup></italic> seminiferous tubules and epididymis compared to WT littermates (testis and epididymis HE stain, n = 10 for each genotype; asterisks indicate mature spermatozoa in the WT). Immunohistochemistry for synaptonemal complex protein 1, SCP-1, confirms complete spermatogenesis arrest at the level primary spermatocytes in <italic>Parl<sup>-/-</sup></italic> testis (testis SCP-1, n = 10 for each genotype). The distribution of SCP-1 expression is confined to primary spermatocytes and is lost in postmeiotic germ cells as they undergo maturation in WT seminiferous tubules. Immunohistochemistry for allograft inflammatory protein 1, AIF-1, reveals the complete absence of spermatids in <italic>Parl<sup>-/-</sup></italic> testis while WT seminiferous tubules are densely populated by AIF-1-positive spermatids at different levels of maturation (testis AIF-1, n = 10 for each genptype). 8-week-old mice with conditional <italic>Parl</italic> deletion driven by the <italic>Nes</italic> promoter in the nervous system and Leydig cells (<italic>Parl <sup>L/L</sup>::Nes<sup>Cre</sup></italic>) display a normal testicular and epididymal histology as well as SCP-1 and AIF-1 immunohistochemistry comparable to WT mice (right column, n = 4). Scale bars, 200 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Quantitative morphometry, cell composition, and meiotic stage evaluation in 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> seminiferous tubules.</title><p>(<bold>A</bold>) Tubule diameters (n = 3 mice for each genotype; 8–12 tubules considered per mouse; p=0.0002). (<bold>B</bold>) Number of total cells/tubule (n = 3 mice for each genotype; 8–12 tubules considered per mouse;. p=0.0009). (<bold>C</bold>) Ratio between SCP-1-positive spermatocytes/total tubular cells (n = 3 mice for each genotype; 8–12 tubules considered per mouse; p=0,0001). (<bold>D</bold>) Percentage of spermatogonia/tubule quantified using c-KIT immunohistochemistry (n = 3 mice for each genotype; 8–12 tubules considered per mouse; p=0.0103). (<bold>E</bold>) Percentage of Sertoli cells/total tubular cells (n = 3 mice for each genotype; 8–12 tubules considered per mouse;. p=0.0382). Sertoli cells were identified by means of WT1 immunohistochemistry. (<bold>F</bold>) Spermatocyte/ Sertoli cells ratio determined as in (<bold>C</bold>) and (<bold>E</bold>) (n = 3 for each genotype). p=0.0021. Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test. (<bold>G</bold>) Immunohistochemistry for γH2AX (n = 3 for each genotype) shows prominent accumulation of pachytene spermatocytes, characterized by the distinct XY body positivity (insets, arrowheads), in <italic>Parl<sup>-/-</sup></italic> tubules. On the contrary, WT testis are populated by less γH2AX-positive spermatocytes with a prevalence of zygotene spermatocytes characterized by the dispersed nuclear immunoreactivity (insets, arrows). Scale bars, 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Nestin expression in Leydig cells.</title><p>Immunohistochemistry for GFP identifies diffuse signal in the Leydig cell population (arrows) of reporter mice with transgenic GFP expression under the <italic>Nes</italic> promoter (n = 3). Scale bar, 50 µm. Expression of <italic>Nes</italic> is expected to result in Cre-mediated deletion of <italic>Parl</italic> in the conditional knockout model <italic>Parl <sup>L/L</sup>::Nes<sup>Cre</sup></italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig1-figsupp2-v3.tif"/></fig></fig-group><p>To determine whether the observed testicular abnormalities are linked to neurodegeneration, mice with conditional deletion of <italic>Parl</italic> in the nervous system (<italic>Parl <sup>L/L</sup>::Nes<sup>Cre</sup></italic>) were studied. Surprisingly, despite developing severe Leigh-like encephalopathy, these mice exhibit normal testicular size, histology, and sperm production comparable to WT littermates (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), demonstrating that the testicular disorder is not a consequence of neurodegeneration. As previously reported (<xref ref-type="bibr" rid="bib5">Anand-Ivell et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Davidoff et al., 2004</xref>), <italic>Nes</italic> is also expressed in Leydig cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Although PARL deficiency <italic>in situ</italic> could not be formally verified in the absence of specific PARL antibodies suitable for immunohistochemistry, Cre recombinase activation under the <italic>Nes</italic> promoter is predicted to effectively delete <italic>Parl</italic> in these cells as in the nervous system. Moreover, extensive morphological observations detailed in the following paragraph indicate that Leydig cells are structurally unaffected in the germline <italic>Parl<sup>-/-</sup></italic> testis (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), suggesting that the spermatogenetic defect is not secondary to PARL deficiency in these cells.</p><p>Altogether, deficiency of PARL leads to a complete arrest of spermatogenesis at the level of primary spermatocytes, independent of the effects of PARL in the nervous system and in Leydig cells.</p></sec><sec id="s2-2"><title>PARL deficiency results in mitochondrial ultrastructural abnormalities and progressive degeneration and death of arrested spermatocytes</title><p>To gain insight into the possible pathological effects of PARL deficiency on germ cells, we conducted a detailed morphological analysis using semithin sections and electron microscopy.</p><p>In unaffected WT animals, germ cells undergo a maturation process, with less differentiated forms (spermatogonia and spermatocytes) in the abluminal layers, more differentiated spermatids in the adluminal compartment, and mature spermatozoa in the lumen of the seminiferous tubules (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Conversely, <italic>Parl<sup>-/-</sup></italic> mice exhibit severe vacuolar degeneration of arrested spermatocytes, leading to cell death, and this degeneration progressively worsens from the abluminal to the adluminal compartment (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Analysis of spermatocyte ultrastructure showed a significant increase in the occurrence of degeneration/death in <italic>Parl<sup>-/-</sup></italic> spermatocytes compared to WT (18.9% degenerated spermatocytes out of 201 analyzed in <italic>Parl<sup>-/-</sup></italic> vs. 0% out of 79 WT spermatocytes analyzed; n = 3 for each genotype; p=0.0002 by two-sided Fisher’s exact test). Next, we assessed whether mitochondrial morphology was affected in PARL-deficient spermatocytes. Differentiation <italic>per se</italic> leads to important morphological adaptations of mitochondria that parallel increasing bioenergetic demands requiring a shift from more glycolytic to more oxidative metabolism (<xref ref-type="bibr" rid="bib91">Varuzhanyan and Chan, 2020</xref>). To ensure accurate comparisons, we focused on primary spermatocytes showing fully assembled synaptonemal complexes, a characteristic feature during the zygotene and pachytene stages of meiotic prophase I (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref ref-type="bibr" rid="bib98">Yang and Wang, 2009</xref>; <xref ref-type="bibr" rid="bib58">Martins and Silva, 2001</xref>). Compared to the mitochondria of WT primary spermatocytes, which are typically small with dilated cristae and dense finely granular matrix, mitochondria of <italic>Parl<sup>-/-</sup></italic> spermatocytes appear consistently swollen with few thin irregular cristae and loss of normal matrix density (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Quantitative analysis of the mitochondrial ultrastructure in primary spermatocytes showed a dramatic increase of degenerating mitochondria in <italic>Parl<sup>-/-</sup></italic> compared to WT spermatocytes (92% of analyzed mitochondria in <italic>Parl<sup>-/-</sup></italic> were abnormal vs. 1.9% in WT; n = 3 for each phenotype; p=0.0002 by two-sided Fisher’s exact test). Importantly, abnormal mitochondrial morphology was the earliest ultrastructural change detected in PARL-deficient spermatocytes localized in the abluminal compartment, while adluminal germ cells exhibited additional abnormalities affecting other cell compartments, including the endoplasmic reticulum, Golgi apparatus, and nuclear envelope. Chromatin clumping and nuclear fragmentation were also evident (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Impaired spermatogenesis in <italic>Parl<sup>-/-</sup></italic> testis is associated with early mitochondrial morphological abnormalities and progressive degeneration of arrested spermatocytes.</title><p>(<bold>A</bold>) Toluidine blue-stained semithin sections of testis from 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice. Seminiferous tubules from <italic>Parl<sup>-/-</sup> mice</italic> show extensive degenerative changes in arrested spermatocytes including tortuous membrane infoldings, cytoplasmic vacuolation (arrows), irregular chromatin clumping, nuclear fragmentation (arrowheads), and absence of mature germ cells such as adluminal spermatids and spermatozoa (n = 3 for each genotype). A WT seminiferous tubule with normal germ cell maturation is shown for comparison (left panel). Scale bars, 20 µm. (<bold>B</bold>) Electron microscopy examination shows multifocal cisternae distention, disruption of the endoplasmic reticulum and Golgi apparatus, and abundant accumulation of damaged membranous material and organelles (asterisks) in <italic>Parl<sup>-/-</sup></italic> spermatocytes. The nuclear envelope is diffusely distended (arrowheads) outlining a convoluted fragmented nucleus (N) with dense irregular clumps of chromatin. A WT spermatocyte at the end of pachytene is shown for comparison (left panel). Scale bars, 1 µm. (<bold>C</bold>) Electron microscopy analysis shows that mitochondria in <italic>Parl<sup>-/-</sup></italic> primary spermatocytes are swollen with few thin irregular cristae and loss of normal matrix density (right panel, arrowheads) compared to WT (left panel, arrowheads). The thin arrows indicate the intermitochondrial cement (nuage) typically associated with mitochondria in primary spermatocytes. The large arrows indicate fully assembled synaptonemal complexes, structures that are only detectable during the zygotene and pachytene stages of meiotic prophase I (n = 3 for each genotype). Scale bars, 0.5 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Ultrastructural abnormalities of mitochondria and other cell compartments are restricted to arrested spermatocytes and absent in other testis cell types.</title><p>(<bold>A</bold>) Degenerating/dying spermatocytes from 5-week-old <italic>Parl<sup>-/-</sup></italic> mice are mainly observed across the adluminal compartment of the seminiferous tubule (left panel, asterisks). At higher magnification (right panel), the cytoplasm of the degenerating spermatocyte shows multifocal cisternae distention and disruption of the endoplasmic reticulum with abundant accumulation of irregular coils of membranous material wrapped around damaged organelles including mitochondria (inset, arrowheads). Irregular nuclear infoldings and chromatin clumping are also evident (n = 3). Scale bars, 5 µm (left panel) and 1 µm (right panel). (<bold>B</bold>) Ultrastructural abnormalities in 5-week-old <italic>Parl<sup>-/-</sup></italic> mice are not evident in spermatogonia, Leydig cells, and Sertoli cells. Spermatogonia (top panel) characterized by large round nuclei (N) and scant cytoplasm with scattered small oval mitochondria with lamellar cristae (arrowheads); scale bar, 0.5 µm. Leydig cells (middle panel) typically characterized by nuclei with a single prominent nucleolus (n), intercellular canaliculi with rudimentary microvillus processes (Can), large round to elongated mitochondria with dense tubular crista (arrowheads), and scattered cytoplasmic lipid droplets (asterisks); scale bar, 1 µm. Cytoplasmic projections of Sertoli cells (bottom panel) with typical round mitochondria characterized by few often dilated tubular cristae (arrowheads) (n = 3 for each genotype). Scale bar, 0.5 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig2-figsupp1-v3.tif"/></fig></fig-group><p>In contrast, other cell types within the seminiferous tubules and surrounding interstitium, such as spermatogonia, Leydig, and Sertoli cells, displayed normal ultrastructural features with preserved mitochondrial morphology (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Altogether, these data indicate the presence of early mitochondrial ultrastructural abnormalities culminating in extensive degeneration and death of arrested PARL-deficient spermatocytes, without morphological evidence of spermatogonia, Leydig cells, or Sertoli cells involvement.</p></sec><sec id="s2-3"><title>Impaired spermatogenesis in PARL<italic>-</italic>deficient testis is not driven by misprocessing of PARL substrates PINK1, PGAM5, and TTC19</title><p>Next, we asked to what extent the severe spermatogenesis defect induced by PARL deficiency can be attributed to the misprocessing and altered maturation of PARL’s substrates. To answer this question, we first tested the testicular expression of established PARL substrates. <italic>Parl<sup>-/-</sup></italic> testis mitochondria exhibit remarkable accumulation of uncleaved PINK1 and PGAM5, as well as almost total lack of the mature form of TTC19 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These findings were consistent with previous observations in the brain (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>) and cultured cells (<xref ref-type="bibr" rid="bib69">Saita et al., 2017</xref>). Since other PARL substrates, such as DIABLO, STARD7, and CLPB, displayed only subtle misprocessing or expression changes, possibly due to compensatory proteolytic cleavage by alternative proteases, we focused our investigation on PINK1, PGAM5, and TTC19. We aimed to determine whether the genetic modulation of these substrates could either modify or reproduce the testicular phenotype observed in <italic>Parl<sup>-/-</sup></italic> mice. In particular, we assessed whether accumulation of uncleaved PINK1 and PGAM5, alone or in combination, or depletion of the cleaved form of PINK1, PGAM5, or TTC19 were the molecular mechanisms underlying the abnormalities documented in <italic>Parl<sup>-/-</sup></italic> testis. PINK1 and PGAM5 are known to play essential roles in maintaining mitochondrial integrity and homeostasis and have been linked to both Parkinson’s disease and defects of spermatogenesis (<xref ref-type="bibr" rid="bib89">Valente et al., 2004</xref>; <xref ref-type="bibr" rid="bib52">Lu et al., 2014</xref>; <xref ref-type="bibr" rid="bib1">Agarwal et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Deng et al., 2008</xref>). Similarly, TTC19 is a mitochondrial protein crucial for the catalytic activity of complex III, and pathogenic variants of TTC19 are associated with mitochondrial diseases in humans, including Leigh syndrome (<xref ref-type="bibr" rid="bib7">Atwal, 2014</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Mice with genetic manipulation of the PARL substrates PINK1, PGAM5, and TTC19 do not reproduce or modify <italic>Parl<sup>-/-</sup></italic> testis phenotype.</title><p>(<bold>A</bold>) Immunoblots of testis mitochondria from 6-week-old WT and <italic>Parl<sup>−/−</sup></italic> mice with antibodies for the established PARL substrates PINK1, PGAM5, TTC19, DIABLO, STARD7, and CLPB. Severe accumulation of unprocessed PINK1 and PGAM5, as well as severe decrease in the mature processed form of TTC19 are evident in <italic>Parl<sup>−/−</sup></italic> testis. HSP60 is the loading control. (<bold>B</bold>) Histology of testes from 7-week-old mice of the indicated genotypes (HE stain, n = 3 for each genotype). <italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup></italic>, <italic>Parl<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic>, and <italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic> show complete lack of sperm production and no modification of the testicular phenotype compared to <italic>Parl<sup>-/-</sup></italic> mice. <italic>Ttc19<sup>-/-<sub>,</sub></sup> Pink1</italic><sup><italic>-/-</italic></sup>, <italic>Pgam5</italic><sup><italic>-/-</italic></sup>, and <italic>Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic> mice have no evident testis pathology and show normal sperm production (mature spermatozoa are indicated by asterisks), and are fertile. Scale bar, 145 µm.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig3-data1-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Similar to what has been described in <italic>Parl<sup>-/-</sup></italic> mice, immunohistochemistry for AIF-1 confirms spermatogenesis arrest with complete absence of spermatids in <italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup></italic>, <italic>Parl<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic>, and <italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic> mice.</title><p>On the contrary, as observed in WT mice, normal seminiferous tubules in <italic>Pink1<sup>-/-</sup>, Pgam5<sup>-/-</sup>, Ttc19<sup>-/-</sup></italic> and <italic>Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic> mice are populated by AIF-1-positive spermatids at different levels of maturation (n = 3 for each genotype).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig3-figsupp1-v3.tif"/></fig></fig-group><p>To test this hypothesis, we analyzed testes from a series of genetically engineered mutant mouse lines, including single-gene knockouts such as <italic>Pink1<sup>-/-</sup>, Pgam5<sup>-/-</sup>,</italic> and <italic>Ttc19<sup>-/-</sup>,</italic> as well as multiple gene knockouts including both <italic>Parl</italic> and <italic>Pink1</italic> (<italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup></italic>); <italic>Parl</italic> and <italic>Pgam5</italic> (<italic>Parl<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic>); <italic>Pink1</italic> and <italic>Pgam5</italic> (<italic>Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic>); and <italic>Parl, Pink1</italic>, and <italic>Pgam5</italic> combined (<italic>Parl<sup>-/-</sup>/Pink1<sup>-/-</sup>/Pgam5<sup>-/-</sup></italic>). Remarkably, the severe testis phenotype resulting from PARL deficiency remained unaltered upon additional deletion of <italic>Pink1</italic> or <italic>Pgam5</italic> either individually or in combination (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In contrast, the single or combined knockouts of <italic>Pink1, Pgam5,</italic> and <italic>Ttc19</italic> resulted in normal fertility and testis morphology, showing orderly and complete spermatogenesis (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In conclusion, these observations indicate that impaired spermatogenesis in PARL-deficient mice is not driven by altered proteolytic maturation of the substrates PINK1, PGAM5, and TTC19 despite their severely affected proteolytic processing, indicating that other pathogenetic mechanisms are responsible for the testis phenotype.</p></sec><sec id="s2-4"><title>PARL-deficient testis mitochondria exhibit severe respiratory chain defects</title><p>Spermatogenesis involves crucial metabolic adaptations, with mitochondrial function playing a critical role throughout germ cell maturation (<xref ref-type="bibr" rid="bib91">Varuzhanyan and Chan, 2020</xref>). Given the interconnection between mitochondrial morphology and function, we investigated the impact of the structural abnormalities identified in the mitochondria of <italic>Parl<sup>-/-</sup></italic> spermatocytes by conducting a comprehensive functional analysis. Because of the previously reported role of PARL in mitochondrial biogenesis (<xref ref-type="bibr" rid="bib18">Civitarese et al., 2010</xref>), we wondered whether mitochondrial mass is reduced in <italic>Parl<sup>-/-</sup></italic> testis. Expression of the outer mitochondrial membrane protein TOMM20 and of the inner membrane ATP synthase beta subunit (ATPB) were similar between WT and <italic>Parl<sup>-/-</sup></italic> testis, suggesting unaltered mitochondrial mass (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig5">Figure 5B</xref>, and <xref ref-type="fig" rid="fig6">Figure 6B</xref>). Similarly, mitochondrial DNA abundance, often used as an indicator of mitochondrial mass, was not significantly different between the two groups (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Additionally, the expression of TFAM, a protein binding mitochondrial DNA in nucleoids (<xref ref-type="bibr" rid="bib24">Ekstrand et al., 2004</xref>), did not show any significant difference between WT and <italic>Parl<sup>-/-</sup></italic> SCP-1-positive spermatocytes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Next, we examined whether mitochondrial respiratory chain complexes were appropriately assembled in <italic>Parl<sup>-/-</sup></italic> testis mitochondria. Blue native gel electrophoresis revealed severe assembly alterations in multiple respiratory chain complexes, including complex I, complex III, complex IV, and to a lesser extent complex V, as well as the supercomplex (<xref ref-type="bibr" rid="bib65">Pérez-Pérez et al., 2016</xref>; <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Since respiratory chain complexes’ supramolecular assembly is required for optimizing the efficiency of mitochondrial oxidative phosphorylation (OXPHOS), we then examined if PARL deficiency ultimately resulted in impaired mitochondrial respiration in testis mitochondria. To answer this question, we measured oxygen consumption by means of high-resolution respirometry in testis mitochondria supplied with substrates and specific inhibitors for complex I (CI), complex II (CII), and complex IV (CIV) as illustrated in <xref ref-type="fig" rid="fig4">Figure 4D</xref>. Basal mitochondrial respiration in presence of complex I substrates but no ADP (CI LEAK) was significantly increased in <italic>Parl<sup>-/-</sup></italic> testis compared to WT, suggesting pathological short-circuit of protons across the inner mitochondrial membrane. Conversely, both phosphorylating respiration, whether driven by complex I only (CI OXPHOS) or by both complex I and II together (CI + II OXPHOS), and maximal uncoupled respiration, whether driven by complex II (CII ET) or by both complex I and II (CI + II ET) were severely diminished in <italic>Parl<sup>-/-</sup></italic> testis mitochondria. Respiration driven by CIV was also decreased. These results localize the severe respiration defect at the level of electron transfer capacity (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). However, the defects were not attributed to cytochrome <italic>c</italic> loss due to outer mitochondrial membrane permeabilization (<xref ref-type="fig" rid="fig4">Figure 4E</xref>; CIV+cytc graph). To gain cell-type insights into the observed electron transport defect, cytochrome <italic>c</italic>-oxidase activity staining was performed on frozen tissue sections. The enzyme function was significantly decreased in PARL-deficient seminiferous tubules but not in Leydig cells, highlighting the specific distribution of the defect (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The expression of the subunit 4 of cytochrome <italic>c</italic>-oxidase, COX4, was indeed severely decreased in <italic>Parl<sup>-/-</sup></italic> SCP-1-positive spermatocytes, confirming the defect in this cell type (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; p=0.0027). This defect was again unrelated to changes in mitochondrial mass since TOMM20 expression was unmodified by PARL deficiency in SCP-1 spermatocytes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Interestingly,e dramatic overexpression of the glucose intracellular transporter GLUT1 was observed in <italic>Parl<sup>-/-</sup></italic> spermatocytes suggesting increased glucose utilization as an adaptive response to disrupted OXPHOS (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). In conclusion, PARL is crucial for maintaining the integrity of the mitochondrial electron transport chain. Its deficiency leads to severe respiratory chain defects and metabolic remodeling in arrested primary spermatocytes.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Severe mitochondrial electron transfer defects in <italic>Parl<sup>-/-</sup></italic> testis mitochondria.</title><p>(<bold>A</bold>) Immunoblots of testis lysates from 5-week-old WT and <italic>Parl<sup>−/−</sup></italic> mice with antibodies for PARL, ATPB, TOMM20, and ACTB (n = 3 for each genotype). ACTB is the loading control. (<bold>B</bold>) Quantification of mitochondrial DNA normalized to nuclear DNA in testis from 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 10 for each genotype). MtDNA was quantified by measuring the ratio (mtDNA/nDNA) between a target mitochondrial gene (<italic>Cox1</italic>) and a reference nuclear gene (<italic>B2m</italic>) using quantitative real-time PCR as detailed in the ‘Methods’ section. No significant difference is found between WT and <italic>Parl<sup>-/-</sup></italic> testis (p=0.9146). (<bold>C</bold>) Blue native gel electrophoresis of testis mitochondria from 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype). Mitochondrial complexes and supercomplex constituted by macromolecular assembly of complex I (CI), complex III (CIII) dimer, and complex IV (CIV) are visualized after staining with Instant Blue and marked by dotted lines. Assembly defects are evident for CI, CIII, CIV, and the supercomplex. (<bold>D</bold>) Representative trace illustrating the protocol for high-resolution respirometry in testis mitochondria. The blue trace indicates the O<sub>2</sub> concentration (nmol/ml), and the red trace indicates its time derivative (pmol of O<sub>2</sub> consumed/s*ml). Testis mitochondria (150 μg) were loaded in Miro6 buffer. Substrates are as follows: CI (PMG, pyruvate + malate + glutamate), CII (Succ, succinate), and CIV (ASC/TMPD, ascorbate + TMPD). The uncoupler is CCCP. The specific mitochondrial inhibitors are rotenone (ROT) for CI, antimycin a (Aa) for CIII, and cyanide (KCN) for CIV. Respiratory states are indicated between red dashed lines. CI LEAK, CI-driven leak respiration, in presence of CI substrates but no adenylates; CI OXPHOS, CI-driven phosphorylating respiration; CI+II OXPHOS, phosphorylating respiration driven by combined activation of CI and II; CI+II ET, electron transfer capacity driven by combined CI and II; CII ET, ET driven by CII; CIV, CIV-driven respiration; CIV+cytc: CIV-driven respiration after addition of exogenous cytochrome <italic>c</italic> to evaluate the integrity of the outer mitochondrial membranes; CIV BG: chemical background of CIV-driven respiration. H<sub>2</sub>O<sub>2</sub> in the presence of catalase is used to reoxygenate the chamber. (<bold>E</bold>) Quantification of the respiratory states of testis mitochondria from 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 6 for each genotype) as from the protocol described in (<bold>D</bold>) and in the ‘Methods’ section. Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test: *p&lt;0.05, **p&lt;0.01,***p&lt;0.001, and ****p&lt;0.0001. (<bold>F</bold>) Cytochrome <italic>c</italic> oxidase histochemistry in frozen testis sections from 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig4-data1-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Unaltered TFAM expression in <italic>Parl<sup>-/-</sup></italic> spermatocytes.</title><p>Normalized quantification of TFAM immunofluorescence in SCP1-positive primary spermatocytes does not reveal significant expression differences between 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 mice for each genotype, 500–1000 SCP-1-positive spermatocytes considered for each mouse; p=0.439). Scale bars, 100 µm. Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig4-figsupp1-v3.tif"/></fig></fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Severe loss of COX4 associated with increased expression of glucose intracellular transporter in <italic>Parl<sup>-/-</sup></italic> spermatocytes.</title><p>(<bold>A</bold>) Quantitative immunofluorescence shows decreased expression of COX4 in SCP-1-positive spermatocytes from 5-week-old <italic>Parl<sup>-/-</sup></italic> mice compared to WT littermates (n = 3 for each genotype, 500–1000 SCP-1-positive spermatocytes for each mouse, two-sided Student’s <italic>t</italic>-test: p=0.0027). Scale bars, 100 µm. Bar graphs indicate average ± SD. (<bold>B</bold>) Normalized quantification of TOMM20 immunofluorescence in SCP-1-positive primary spermatocytes does not reveal significant differences in mitochondrial mass in the two different genotypes (n = 3 mice for each genotype, 500–1000 SCP-1-positive spermatocytes considered for each mouse; p=0.821). Scale bars, 100 µm. Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test. (<bold>C</bold>) GLUT1 immunohistochemistry of testis from 5-week-old mice shows prominent overexpression of GLUT1 in arrested <italic>Parl<sup>-/-</sup></italic> spermatocytes, and low levels in WT (arrowheads) (n = 3 for each genotype). Scale bars, 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig5-v3.tif"/></fig><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Severe alteration in coenzyme Q (CoQ) biosynthesis and redox state in <italic>Parl<sup>-/-</sup></italic> testis.</title><p>(<bold>A</bold>) Concentration (left) and CoQ red/ox ratio (right) of total CoQ (Q<sub>9</sub> + Q<sub>10</sub>) measured by HPLC in the testes of 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 5 for each genotype). Total CoQ levels are severely decreased in <italic>Parl<sup>-/-</sup></italic> testis compared to WT littermates (p=0.0001 calculated by two-sided Student’s <italic>t</italic>-test). Moreover, the redox status is altered with drastic elevation in the reduced/oxidized CoQ ratio (p&lt;0,0001 calculated by two-sided Student’s <italic>t</italic>-test). (<bold>B</bold>) Immunoblot analysis of total testis lysates from 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice with antibodies for COQ4, TOMM20, and ACTB (n = 3 for each genotype). ACTB is the total lysate loading control. TOMM20 is the mitochondrial content control. Quantification of COQ4/TOMM20 confirms a significant decrease in <italic>Parl<sup>-/-</sup></italic> testis compared to WT littermates (n = 3; p=0,0212 calculated by two-sided Student’s <italic>t</italic>-test.) but unchanged TOMM20/ACTB (n = 3; p=0,368 calculated by two-sided Student’s <italic>t</italic>-test), indicating that the observed decrease in COQ expression is not explained by decreased mitochondrial mass. Bar graphs indicate average ± SD. (<bold>C</bold>) Immunohistochemistry for COQ4 shows severely decreased levels of testicular COQ4 expression in 5-week-old <italic>Parl<sup>-/-</sup></italic> mice compared to WT controls (n = 3 for each genotype). The deficit is particularly prominent in <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes, almost devoid of COQ4 expression, compared to the high constitutive levels of COQ4 expression in WT spermatocytes (inset, stage II tubule, arrowheads). Decreased COQ4 expression is also evident in <italic>Parl<sup>-/-</sup></italic> Leydig cells compared to WT mice (insets, asterisk). In addition, COQ4-positive Sertoli cell projections observed in WT mice (inset, stage II tubule, arrows) are not evident in the seminiferous tubules of <italic>Parl<sup>-/-</sup></italic> mice. Scale bar, 100 µm.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig6-data1-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Severe loss of COQ4 in <italic>Parl<sup>-/-</sup></italic> spermatocytes.</title><p>Normalized quantification of COQ4 immunofluorescence in SCP1-positive primary spermatocytes shows significantly higher levels of expression in 5-week-old WT compared to <italic>Parl<sup>-/-</sup></italic> mice (n = 3 mice for each genotype, 500–1000 SCP-1-positive spermatocytes considered for each mouse, p=0.0047). Scale bars, 100 µm. Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig6-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-5"><title>PARL deficiency causes impaired testicular CoQ biogenesis and redox</title><p>CoQ is a lipid essential for cellular functions, serving both as an electron carrier in the mitochondrial respiratory chain and as a lipophilic antioxidant, preventing lipid peroxidation (<xref ref-type="bibr" rid="bib34">Gueguen et al., 2021</xref>). In mammalian mitochondria, CoQ is involved in multiple converging pathways for its reduction, including complex I, complex II, dehydro-orotate dehydrogenase, sulfide-quinone oxidoreductase, and electron transfer dehydrogenase, while complex III is responsible for its oxidation. CoQ plays a critical role in promoting testicular functions including the maturation of male germ cells by safeguarding against oxidative damage (<xref ref-type="bibr" rid="bib49">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Mancini and Balercia, 2011</xref>).</p><p>In previous studies, we showed that brain mitochondria from PARL-deficient mice have decreased CoQ concentration linked to impaired expression of the ubiquinone biosynthesis protein COQ4 homolog, mitochondrial COQ4 (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>), a protein required for the biosynthesis of CoQ (<xref ref-type="bibr" rid="bib93">Wang and Hekimi, 2019</xref>). Additionally, we observed an increase in the reduced-to-oxidized CoQ ratio (CoQ red/ox) in neurons due to TTC19 deficiency, leading to complex III dysfunction (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). Similarly, we found significantly decreased CoQ levels in <italic>Parl<sup>-/-</sup></italic> testis, accompanied by a dramatic increase in the CoQ red/ox (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This elevation in CoQ reduction can be attributed to impaired CoQH<sub>2</sub> oxidation, resulting from compromised complex III activity caused by TTC19 depletion (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and complex III assembly defects (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Notably, we also noticed a substantial decrease in COQ4 levels in <italic>Parl<sup>-/-</sup></italic> testis, as seen in the brain (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). Western blotting (<xref ref-type="fig" rid="fig6">Figure 6B</xref>) and immunohistochemistry (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) revealed a diffuse decrease in COQ4 expression in various cell types, including germ cells, Leydig cells, and Sertoli cells. The deficit was particularly pronounced in <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes, even those with no or minimal degenerative changes, suggesting that the CoQ biosynthesis defect occurred upstream of the degenerative process. Quantitative immunofluorescence of COQ4 expression confirms severe deficiency of this protein in <italic>Parl<sup>-/-</sup></italic> SCP-1-positive spermatocytes compared to WT littermates (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Collectively, our findings indicate that PARL plays a crucial role in maintaining CoQ biosynthesis and redox state.</p></sec><sec id="s2-6"><title>PARL deficiency leads to ferroptosis in arrested spermatocytes</title><p>To understand the specific mechanism responsible for the severe germ cell degeneration and death observed in PARL-deficient mice, we first considered apoptosis due to the characteristic ultrastructural features observed in arrested spermatocytes (i.e., chromatin clumping and nuclear fragmentation) and previous links of PARL to antiapoptotic properties <italic>in vitro (</italic><xref ref-type="bibr" rid="bib17">Cipolat et al., 2006</xref>). However, levels of caspase-3 activation in the seminiferous tubules of <italic>Parl<sup>-/-</sup></italic> mice were comparable to WT, suggesting that apoptosis was not significantly involved in this phenotype (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Given the identification of decreased CoQ concentration and severe ultrastructural abnormalities involving mitochondria and other membranous cell compartments, we speculated about the possible role of ferroptosis. Ferroptosis is a programmed cell death modality characterized by lipid peroxidation of cell membranes (<xref ref-type="bibr" rid="bib82">Stockwell et al., 2017</xref>; <xref ref-type="bibr" rid="bib70">Santoro, 2020</xref>). Previous studies in cultured cells have shown the importance of CoQ producing mevalonate pathway (<xref ref-type="bibr" rid="bib77">Shimada et al., 2016</xref>) and CoQ reducing pathways driven by FSP1 (<xref ref-type="bibr" rid="bib8">Bersuker et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Doll et al., 2019</xref>), DHODH (<xref ref-type="bibr" rid="bib56">Mao et al., 2021</xref>), and GCH1 (<xref ref-type="bibr" rid="bib46">Kraft et al., 2020</xref>) in ferroptosis. To test this hypothesis, we examined the expression of GPX4, a crucial antioxidant peroxidase that prevents ferroptosis by reducing phospholipid hydroperoxide in cell membranes using reduced glutathione as substrate (<xref ref-type="bibr" rid="bib16">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib73">Seibt et al., 2019</xref>). Immunoblot analysis revealed a nearly complete absence of GPX4 expression in <italic>Parl<sup>-/-</sup></italic> testis (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Immunohistochemistry and immunofluorescence provided cell-type-specific insights, showing a dramatic decrease in GPX4 expression in <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, top panels; <xref ref-type="fig" rid="fig8">Figure 8A</xref>, p=0.0013) but not in Leydig (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, top panels, black arrowheads) or Sertoli cells (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>; p=0.5313). The impact of PARL deficiency on GPX4 expression was not observed in other organs, indicating a specific effect on spermatocytes (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>). To rule out a possible effect of PARL proteolytic activity on GPX4 expression, we checked GPX4 expression in mouse embryonic fibroblasts with and without PARL expression, and knockouts rescued with proteolytically active or inactive PARL. The results do not show evidence of proteolytic misprocessing and do not indicate GPX4 as a direct substrate of PARL (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B</xref>). Further investigations demonstrated increased lipid peroxidation, as evidenced by significantly higher levels of 4-hydroxynonenal (HNE) adducts, the end-products of lipid peroxidation that defines ferroptosis, in <italic>Parl<sup>-/-</sup></italic> testis (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, middle panel), but not in brain (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>). The accumulation of HNE adducts was particularly prominent in adluminal and exfoliated spermatocytes during the late stages of degeneration (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, middle panels). We confirmed these data by quantitative immunofluorescence showing a dramatic increase in HNE signal in SCP-1 positive <italic>Parl<sup>-/-</sup></italic> spermatocytes (<xref ref-type="fig" rid="fig8">Figure 8B</xref>; p=0.0002), which is consistent with the specific loss of GPX4 expression in these cells.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Massive ferroptosis activation in <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes.</title><p>(<bold>A</bold>) Immunoblot of total testis lysates obtained from 5-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice using antibodies for GPX4, TOMM20, and ACTB (n = 3 for each genotype). ACTB is the loading control. GPX4 expression is barely detectable in <italic>Parl<sup>-/-</sup></italic> testis. (<bold>B</bold>) Immunoblot analysis of total testis lysates from 7-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice using anti-HNE and anti-ACTB antibodies (n = 3 for each genotype). ACTB is the loading control. Quantification of the HNE/ACTB ratio is shown on the right as a graph indicating average ± SD (n = 3 for each genotype). The statistically significant HNE/ACTB ratio increase in <italic>Parl<sup>-/-</sup></italic> mice has been calculated by two-sided Student’s <italic>t</italic>-test (p=0.0199). (<bold>C</bold>) Immunohistochemistry for GPX4, HNE, and TfR1 in testis from 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype). GPX4 expression is barely detectable in <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes compared to WT littermates (inset, stage X tubule, white arrowheads), while it is unaffected in interstitial Leydig cells (black arrowheads) (top panels, scale bar, 100 um). HNE immunohistochemistry shows gradual intensification of lipid peroxidation during spermatocyte degeneration culminating in adluminal/exfoliated spermatocytes (inset, arrowheads) (middle panels; scale bar, 200 µm). Similarly, TfR1 expression is abnormally increased in degenerating <italic>Parl<sup>-/-</sup></italic> spermatocytes (bottom panels; scale bars, 200 µm; inset, arrowheads).</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-data2-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig7-v3.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Unremarkable levels of apoptosis activation in degenerated <italic>Parl<sup>-/-</sup></italic> testis.</title><p>Cleaved-caspase-3 immunohistochemistry on testis from 5-week-old <italic>Parl<sup>-/-</sup></italic> mice and WT littermates (n = 3 for each genotype). The maturation defect and degenerative changes of PARL<italic>-</italic>deficient seminiferous tubules are not associated with a significant increase of caspase-dependent apoptotic cell death as confirmed by sporadic cleaved caspase-3 expression with no substantial differences among the two genotypes (left panel). Arrowheads indicate occasional apoptotic cells in the seminiferous tubules. Scale bar, 50 µm. Quantification of caspase 3-positive cells/tubule, does not show significant differences between 5-week-old <italic>Parl<sup>-/-</sup></italic> and WT mice (right panel; p=0,374). Between 13,000 and 16,000 cells were analyzed from each animal (n = 3 mice for each genotype). Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig7-figsupp1-v3.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Lack of effect of PARL proteolytic activity on GPX4 expression <italic>in vitro</italic> and testis-specific induction of ferroptosis in PARL-deficient mice.</title><p>(<bold>A</bold>) Mitochondria isolated from brain, liver, and testis of 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype) were immunoblotted with antibodies for GPX4 and HSP60. HSP60 is the loading controls. GPX4 deficiency is evident in mitochondria isolated from <italic>Parl<sup>-/-</sup></italic> testis, but not from other organs. (<bold>B</bold>) 20 µg of total protein from WT and <italic>Parl<sup>-/-</sup></italic> mouse embryonic fibroblasts (MEFs) complemented or not with WT or catalytic inactive PARL S275A were separated by SDS PAGE and immunoblotted with GPX4 antibody. Citrate synthase (CS) is the loading control. (<bold>C</bold>) Brain and testis total lysates obtained from 6-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype) were immunoblotted with antibodies for HNE and ACTB. ACTB is the loading control. In absence of PARL, lipid peroxidation is specifically increased in testis but not in the brain.</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-figsupp2-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig7s2sdata2"><label>Figure 7—figure supplement 2—source data 2.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-figsupp2-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig7s2sdata3"><label>Figure 7—figure supplement 2—source data 3.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-figsupp2-data3-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig7-figsupp2-v3.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Increased activation of p53 in PARL-deficient spermatocytes undergoing ferroptosis.</title><p>(<bold>A</bold>) Immunoblot analysis of testis total lysates from 7-week-old WT and <italic>Parl<sup>-/-</sup></italic> mice (n = 3 for each genotype) with antibodies for p53 and ACTB. ACTB is the loading control. <italic>Parl<sup>-/-</sup></italic> testes shows increased levels of p53 compared to WT littermates. (<bold>B</bold>) Immunohistochemical analysis confirms increased p53 expression in the seminiferous tubules of 7-week-old <italic>Parl<sup>-/-</sup></italic> mice compared to WT controls (n = 3 for each genotype). Nuclear immunolabeling is mainly detectable in the adluminal and exfoliated multinucleated spermatocytes (inset) suggesting that p53 upregulation in <italic>Parl<sup>-/-</sup></italic> testis takes place during the late stages of degeneration. No p53 expression is detectable via immunohistochemistry in WT littermates. Scale bars, 200 µm.</p><p><supplementary-material id="fig7s3sdata1"><label>Figure 7—figure supplement 3—source data 1.</label><caption><title>Original images for <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84710-fig7-figsupp3-data1-v3.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig7-figsupp3-v3.tif"/></fig></fig-group><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Hallmarks of ferroptosis in <italic>Parl<sup>-/-</sup></italic> primary spermatocytes.</title><p>(<bold>A</bold>) Quantitative immunofluorescence shows severely reduced GPX4 expression in SCP-1-positive primary spermatocytes from 5-week-old <italic>Parl<sup>-/-</sup></italic> mice compared to WT littermates (n = 3 mice for each genotype, 500–1000 SCP-1-positive spermatocytes considered for each mouse, p=0.0013). (<bold>B</bold>) Quantitative immunofluorescence shows increased HNE accumulation in <italic>Parl<sup>-/-</sup></italic> SCP-1-positive spermatocytes compared to WT littermates (n = 3 mice for each genotype, 500–1000 SCP-1-positive spermatocytes considered for each mouse, p=0.0002). Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test. Scale bars, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig8-v3.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Unchanged GPX4 expression in <italic>Parl<sup>-/-</sup></italic> Sertoli cells.</title><p>Quantitative immunofluorescence in WT and <italic>Parl<sup>-/-</sup></italic> tubules shows very low expression of GPX4 in Vimentin-positive Sertoli cells of both genotypes. Normalized quantification of GPX4 immunofluorescence in Vimentin-positive Sertoli cells does not reveal significant expression differences between WT and <italic>Parl<sup>-/-</sup></italic> 5-week-old mice (n = 3 mice for each genotype; 300–330 Vimentin-positive Sertoli cells considered for each mouse, p=0,5313). Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student’s <italic>t</italic>-test. Scale bars, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig8-figsupp1-v3.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Increased transferrin receptor expression in <italic>Parl<sup>-/-</sup></italic> spermatocytes undergoing ferroptosis.</title><p>Normalized quantification of TfR1 immunofluorescence in SCP1-positive spermatocytes shows significantly higher levels of expression in 5-week-old <italic>Parl<sup>-/-</sup></italic> mice compared to WT littermates (n = 4 mice for each genotype, 500–100 SCP-1-positive spermatocytes considered for each mouse, p=0.0229). Bar graphs indicate average ± SD. Statistical significance calculated by two-sided Student <italic>t</italic>-test. Scale bars, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig8-figsupp2-v3.tif"/></fig></fig-group><p>Additional established biomarkers of ferroptosis, including cellular tumor antigen p53, a master regulator of both canonical and non-canonical ferroptosis pathways (<xref ref-type="bibr" rid="bib42">Jiang et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Liu and Gu, 2022</xref>), and transferrin receptor protein 1 (TfR1), which promotes the cellular uptake of iron via receptor-mediated endocytosis (<xref ref-type="bibr" rid="bib26">Feng et al., 2020</xref>), were also investigated. Excessive intracellular iron can contribute to ferroptosis by triggering lipid peroxidation through Fenton's reaction. In normal postpubertal mice, expression of p53 levels in testis is very low (<xref ref-type="bibr" rid="bib9">Beumer et al., 1998</xref>) while TfR1 is very high in spermatogonia and gradually decreases during germ cell maturation (<xref ref-type="bibr" rid="bib48">Leichtmann-Bardoogo et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Gao et al., 2021</xref>; <xref ref-type="fig" rid="fig7">Figure 7C</xref>, bottom panel). In contrast, PARL-deficient testis showed prominent nuclear expression of p53 in adluminal degenerating spermatocytes (<xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>), while TfR1 exhibited persistent overexpression in arrested spermatocytes (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, bottom panel), suggesting abnormally high iron uptake. We confirmed these data by quantitative immunofluorescence showing increased TfR1 expression in <italic>Parl<sup>-/-</sup></italic> SCP-1-positive spermatocytes compared to WT littermates (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>; p=0.0229). These findings collectively indicate that ferroptosis is a cell-type-specific effect of PARL deficiency and the mechanism underlying the demise of <italic>Parl<sup>-/-</sup></italic> arrested spermatocytes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>This study sheds light on the critical role of PARL in spermatogenesis and germ cell survival by maintaining the mitochondrial respiratory chain, CoQ biogenesis, and regulating ferroptosis. The reported testicular phenotype represents the earliest manifestation of PARL deficiency. Interestingly, similar spermatogenic defects and neurodegeneration have been reported in <italic>Drosophila</italic> mutants lacking the mitochondrial rhomboid orthologue Rhomboid-7, suggesting that the physiological roles of the mitochondrial rhomboid in these tissues are conserved across different phyla in the animal kingdom (<xref ref-type="bibr" rid="bib59">McQuibban et al., 2006</xref>; <xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). Impaired spermatogenesis in the <italic>Parl<sup>-/-</sup></italic> mouse is characterized by a complete maturation arrest before the completion of the first meiotic division, leading to the induction of ferroptosis in primary spermatocytes. This meiotic failure seems to be related to severe morphological abnormalities of mitochondria and respiratory chain defects. This finding reinforces the crucial role of mitochondrial fitness in supporting germ cell differentiation during spermatogenesis, as previously observed in other mouse models with mitochondrial impairment including defective mitochondrial DNA (<xref ref-type="bibr" rid="bib88">Trifunovic et al., 2004</xref>; <xref ref-type="bibr" rid="bib62">Nakada et al., 2006</xref>), adenylates transport (<xref ref-type="bibr" rid="bib12">Brower et al., 2009</xref>), cardiolipin biosynthesis (<xref ref-type="bibr" rid="bib13">Cadalbert et al., 2015</xref>), mitochondrial dynamics (<xref ref-type="bibr" rid="bib90">Varuzhanyan et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Varuzhanyan et al., 2021</xref>), and mitochondrial proteolysis (<xref ref-type="bibr" rid="bib32">Gispert et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Lu et al., 2008</xref>). In our model, respiratory chain defects involve the assembly and function of multiple complexes, as well as the biosynthesis of the electron carrier CoQ. These results corroborate earlier observations in <italic>Parl<sup>-/-</sup></italic> brain (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>) and recently published studies confirming impaired CoQ biogenesis in <italic>PARL<sup>-/-</sup></italic> cell culture models (<xref ref-type="bibr" rid="bib21">Deshwal et al., 2023</xref>). Collectively, these data underscore a crucial but previously underestimated role of PARL in maintaining the respiratory chain, CoQ biosynthesis, and mitochondrial structure (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>).</p><p>The reason for the pronounced respiratory chain defects and mitochondrial abnormalities in spermatocytes compared to other cell types is not entirely clear. However, we speculate that these differences may arise from cell-type-specific metabolic requirements. Normal spermatogenesis requires a significant metabolic remodeling, with a shift from glycolysis to oxidative phosphorylation to support the energy demand for completing the first meiotic division (<xref ref-type="bibr" rid="bib94">Wang et al., 2022</xref>). In the absence of PARL, primary spermatocytes seem unable to implement oxidative phosphorylation due to their defective respiratory chain, leading to meiotic arrest, despite compensating with increased intracellular glucose uptake . These findings suggest that this phenotype is mainly driven by a germ cell-autonomous defect. Further investigations using germ-cell-specific <italic>Parl</italic> conditional knockout mice may help elucidate the contribution of somatic cells to this phenotype.</p><p>PARL deficiency in spermatocytes leads to maturation arrest and progressive degeneration of germ cells, culminating in the activation of ferroptosis, a specific type of regulated necrosis (<xref ref-type="bibr" rid="bib73">Seibt et al., 2019</xref>). While PARL’s essential role in cell survival has been established (<xref ref-type="bibr" rid="bib79">Spinazzi and De Strooper, 2016</xref>), its relationship with apoptosis remains contradictory in cellular models (<xref ref-type="bibr" rid="bib69">Saita et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Cipolat et al., 2006</xref>). Recent findings indicate that PARL deficiency induces necrosis rather than apoptosis in the brain (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). Although we cannot rule out the contribution of accidental necrosis, since no specific markers are actually available for this cell death modality, this study highlights the specific induction of ferroptosis as the primary mechanism leading to the demise of PARL-deficient spermatocytes.</p><p>Ferroptosis represents a specific type of regulated cell death, characterized by uncontrolled iron-dependent lipid peroxidation of cell membranes (<xref ref-type="bibr" rid="bib16">Chen et al., 2021</xref>). The presence of ferroptosis in PARL-deficient spermatocytes is evidenced by the dramatic accumulation of HNE, an electrophilic aldehyde generated by lipid peroxidation, and impaired expression of the ferroptosis suppressor GPX4. While ferroptosis has been documented in germ cells from <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib64">Perez et al., 2020</xref>), it has not been extensively studied in mammalian spermatogenesis. In this context, our study provides evidence <italic>in vivo</italic> for the implication of ferroptosis during impaired spermatogenesis in a mammalian model. Ferroptosis can be experimentally induced <italic>in vitro</italic> by chemical or genetic inhibition of GPX4, or depletion of its substrate glutathione (<xref ref-type="bibr" rid="bib100">Zheng and Conrad, 2020</xref>; <xref ref-type="bibr" rid="bib82">Stockwell et al., 2017</xref>). Although much of what is known today about ferroptosis comes from <italic>in vitro</italic> experiments or studies in organisms with genetic inactivation of GPX4, its pathophysiological implication in diseases is rapidly emerging (<xref ref-type="bibr" rid="bib83">Stockwell, 2022</xref>). GPX4 exists in three distinct isoforms originating from different transcription initiation sites: a full-length mitochondrial form, a shorter cytosolic form, and a nuclear isoform (<xref ref-type="bibr" rid="bib54">Maiorino et al., 2003</xref>). GPX4 expression is highest in testis, where the mitochondrial isoform is mainly expressed (<xref ref-type="bibr" rid="bib33">Godeas et al., 1997</xref>). Germline deletion of <italic>Gpx4</italic> in mice results in embryonic lethality (<xref ref-type="bibr" rid="bib99">Yant et al., 2003</xref>), while tissue-specific deletions lead to premature death (<xref ref-type="bibr" rid="bib74">Seiler et al., 2008</xref>; <xref ref-type="bibr" rid="bib85">Tan et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Friedmann Angeli et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Carlson et al., 2016</xref>; <xref ref-type="bibr" rid="bib95">Wortmann et al., 2013</xref>). Notably, spermatocyte-specific <italic>Gpx4</italic> deletion in mice causes severe testicular atrophy, reduced spermatogenesis, germ cell death, and infertility (<xref ref-type="bibr" rid="bib38">Imai et al., 2009</xref>), highlighting its importance in male reproductive biology. Reduced GPX4 activity is also observed in the sperm of infertile patients, emphasizing its role in human spermatogenesis (<xref ref-type="bibr" rid="bib37">Imai et al., 2001</xref>; <xref ref-type="bibr" rid="bib27">Foresta et al., 2002</xref>; <xref ref-type="bibr" rid="bib35">Hao et al., 2023</xref>).</p><p>In addition to GPX4, other defense mechanisms against ferroptosis have been described, including CoQ, which provides powerful protection from lipid peroxidation in cell membranes (<xref ref-type="bibr" rid="bib34">Gueguen et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Bersuker et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Doll et al., 2019</xref>; <xref ref-type="bibr" rid="bib56">Mao et al., 2021</xref>; <xref ref-type="bibr" rid="bib85">Tan et al., 2021</xref>). Although the contribution of mitochondria to ferroptosis is still being debated (<xref ref-type="bibr" rid="bib100">Zheng and Conrad, 2020</xref>), cumulating evidence indicates that mitochondria are implicated in this process (<xref ref-type="bibr" rid="bib30">Gao et al., 2019</xref>). CoQ is in fact most abundant in mitochondria, where its biosynthesis takes place, and from which CoQ is then distributed to other cell membranes including the plasma membrane, Golgi apparatus, and endoplasmic reticulum (<xref ref-type="bibr" rid="bib34">Gueguen et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Stefely and Pagliarini, 2017</xref>). Moreover, in cancer cells treated with GPX4 inhibitors to induce ferroptosis, dihydroorotate dehydrogenase DHODH, a mitochondrial inner membrane enzyme involved in pyrimidine biosynthesis, inhibits ferroptosis by reducing CoQ (<xref ref-type="bibr" rid="bib56">Mao et al., 2021</xref>), suggesting that mitochondrial CoQ reduction inhibits ferroptosis. Although the lack of GPX4 is <italic>per se</italic> sufficient to induce ferroptosis in <italic>Parl<sup>-/-</sup></italic> spermatocytes, the process appears exacerbated by the concomitant CoQ deficiency. The functional interaction between PARL, GPX4, and CoQ in the determination of ferroptosis is consistent with a recent study, published during the revision of our manuscript, reporting increased susceptibility of <italic>PARL<sup>-/-</sup></italic> cultured cells to ferroptosis induction by GPX4 inhibitors (<xref ref-type="bibr" rid="bib21">Deshwal et al., 2023</xref>). The underlying mechanism involved defective CoQ biosynthesis and intracellular distribution outside mitochondria mediated by the PARL substrate STARD7 (<xref ref-type="bibr" rid="bib21">Deshwal et al., 2023</xref>). Altogether, these converging results demonstrate the implication of PARL in the regulation of ferroptosis in specific conditions, both <italic>in vitro</italic> and <italic>in vivo</italic>. Interestingly, GPX4 is not a PARL substrate, hence the mechanism beyond GPX4 loss in this cell type remains currently unclear. One possibility is that GPX4 deficiency may result from protein degradation linked to chaperon-mediated autophagy, as reported in cells treated with the ferroptosis inducer erastin (<xref ref-type="bibr" rid="bib96">Wu et al., 2019</xref>), but we cannot rule out a spermatocyte-specific effect on <italic>Gpx4</italic> gene expression either. Interestingly, some interdependence between GPX4 and CoQ is suggested by overlapping inhibitory effects of the ferroptosis inducer FIN56 (<xref ref-type="bibr" rid="bib77">Shimada et al., 2016</xref>) on both CoQ and GPX4 and by the influence of mevalonate pathway on the isopentenylation of selenocysteine-tRNA (<xref ref-type="bibr" rid="bib61">Moosmann and Behl, 2004</xref>) needed for efficient GPX4 expression. Moreover, GPX4 deficit has been previously found in the brain of CoQ-deficient <italic>Coq9<sup>R239X</sup></italic> mice (<xref ref-type="bibr" rid="bib53">Luna-Sánchez et al., 2017</xref>), suggesting that GPX4 loss and ferroptosis may be an overlooked mechanism of CoQ deficiency deserving further investigations. The reason why only spermatocytes undergo ferroptosis in absence of PARL is likely related to the specific loss of GPX4 expression. The distinct vulnerability of spermatocytes might also be influenced by the high poly-unsaturated fatty acid content in these cells (<xref ref-type="bibr" rid="bib63">Oresti et al., 2010</xref>). This peculiar feature could render spermatocytes exceptionally susceptible to lipid peroxidation in the context of the observed CoQ deficiency. This observation provides an important example of how specific phenotypes of mitochondrial diseases can be caused by unexpected cell-type-specific pathophysiological mechanisms downstream of mitochondrial dysfunction. Similar observations can provide some explanations for our very limited understanding of the tissue-specific clinical manifestations of mitochondrial diseases.</p><p>Knowledge of the physiological relevance of ferroptosis in mitochondrial diseases is limited. Compensatory activation of ferroptosis-inhibitory pathways has been recently reported in some conditions of mitochondrial deficiencies. In hearts from mice with different types of mitochondrial dysfunction, such as mitochondrial genome expression defects (<xref ref-type="bibr" rid="bib47">Kühl et al., 2017</xref>) or cytochrome <italic>c</italic> oxidase deficiency (<xref ref-type="bibr" rid="bib3">Ahola et al., 2022</xref>), GPX4 expression increases. Ahola and collaborators have elegantly shown that upregulation of GPX4, sustained by increased glutathione metabolism via the trans-sulphuration pathway and improved selenium incorporation in GPX4, provides a crucial homeostatic response to prevent ferroptosis in heart tissue of <italic>Cox10<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib3">Ahola et al., 2022</xref>). Impairing GPX4 upregulation induced by OXPHOS deficiency through the inhibition of the integrated stress response, by knocking out either the mitochondrial protease OMA1 or its substrate DELE1, aggravates the cardiomyopathy of <italic>Cox10<sup>-/-</sup></italic> mice by decreasing GPX4 to WT levels, thus inducing ferroptosis (<xref ref-type="bibr" rid="bib3">Ahola et al., 2022</xref>). Moreover, direct ablation of GPX4 in cultured cells affected by defective OXPHOS induced by a variety of mitochondrial respiratory chain inhibitors is lethal (<xref ref-type="bibr" rid="bib87">To et al., 2019</xref>). These data clearly demonstrate that prevention of ferroptosis by means of GPX4 upregulation is a required physiological mechanism to prevent cell death in conditions of defective OXPHOS. Our study provides <italic>in vivo</italic> evidence for this mechanism by showing the opposite situation: ferroptosis is spontaneously initiated in PARL-deficient spermatocytes unable to tune up ferroptosis inhibitory pathways in response to OXPHOS deficiency.</p><p>In conclusion, this work establishes PARL’s crucial role in spermatogenesis and prevention of germ cell ferroptosis by maintaining the integrity of mitochondrial structure, electron transport chain, CoQ biosynthesis, and GPX4 expression in spermatocytes (<xref ref-type="fig" rid="fig9">Figure 9</xref>). The discovery of ferroptosis as a consequence of primary mitochondrial defects advances our understanding of the pathophysiology of mitochondrial diseases and male infertility, offering potential targets for future therapeutic interventions.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Cartoon illustrating the identified mechanisms underlying the spermatogenesis defect of <italic>Parl<sup>-/-</sup></italic> mice and the induction of spermatocyte ferroptosis.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84710-fig9-v3.tif"/></fig></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.129P2(Cg)-<italic>Parl</italic><sup><italic>tm1.1Bdes</italic></sup>/Ieg</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16839884/">16839884</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_EM:02075">IMSR_EM:02075</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">B6.129P2-<italic>Parl</italic><sup><italic>tm1Bdes</italic></sup>/Ieg</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16839884/">16839884</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_EM:02076">IMSR_EM:02076</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Tg(Nes-cre)1Kln; <italic>Parl</italic><sup><italic>tm1Bde</italic>s</sup>/<italic>Parl</italic><sup><italic>tm1Bdes</italic></sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10471508/">10471508</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:6280694">MGI:6280694</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Parl</italic><sup><italic>tm1.1Bdes</italic></sup>/<italic>Parl</italic><sup><italic>tm1.1Bdes</italic></sup>;<break/> <italic>Pgam5</italic><sup><italic>tm1d(EUCOMM)Wtsi</italic></sup>/<break/><italic>Pgam5</italic><sup><italic>tm1d(EUCOMM)Wtsi</italic></sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30578322/">30578322</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:6280688">MGI:6280688</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Parl</italic><sup><italic>tm1.1Bdes</italic></sup>/<italic>Parl</italic><sup><italic>tm1.1Bdes</italic></sup>; <italic>Pink1</italic><sup><italic>tm1.1Wrst</italic></sup>/<italic>Pink1</italic><sup><italic>tm1.1Wrst</italic></sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20049710/">20049710</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:6280687">MGI:6280687</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J-<italic>Ttc19</italic><sup><italic>em1Bds</italic></sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30578322/">30578322</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:6280684">MGI:6280684</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">WT, <italic>Parl-/-</italic>, <italic>Parl-/-</italic>+<italic>Parl</italic><sup><italic>WT</italic></sup>, <italic>Parl-/-</italic>+<italic>Parl</italic><sup><italic>S275A</italic></sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30578322/">30578322</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:2159769">MGI:2159769</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SCP-1 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab175191</td><td align="left" valign="bottom">IHC 1:200, IF 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-AIF1 (rabbit polyclonal)</td><td align="left" valign="bottom">Wako</td><td align="left" valign="bottom">Cat#: 019-19741;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_839504">AB_839504</ext-link></td><td align="left" valign="bottom">IHC 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-COQ4 (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">Cat#: 16654-1AP;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2878296">AB_2878296</ext-link></td><td align="left" valign="bottom">IF 1:800, IHC 1:200, WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GPX4 (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: HPA047224;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2679990">AB_2679990</ext-link></td><td align="left" valign="bottom">IHC 1:100, IF 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HNE (rabbit polyclonal)</td><td align="left" valign="bottom">Alpha Diagnostic International</td><td align="left" valign="bottom">Cat#: HNE11-S;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629282">AB_2629282</ext-link></td><td align="left" valign="bottom">IF 1:10,000, IHC 1:3000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TFR1 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab214039;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2904534">AB_2904534</ext-link></td><td align="left" valign="bottom">IF 1:3000, IHC 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p53 (rabbit polyclonal)</td><td align="left" valign="bottom">Leica/Novocastra</td><td align="left" valign="bottom">Cat#: NCL-L-p53-CM5p;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2895247">AB_2895247</ext-link></td><td align="left" valign="bottom">IHC 1:300</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p53 (mouse monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">(1C12) Mouse mAb #2524;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331743">AB_331743</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Wilm’s tumor 1 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab89901;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2043201">AB_2043201</ext-link></td><td align="left" valign="bottom">IF 1:1500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-cKit (rabbit polyclonal)</td><td align="left" valign="bottom">Agilent/DAKO</td><td align="left" valign="bottom">Cat#: A4502;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2335702">AB_2335702</ext-link></td><td align="left" valign="bottom">IHC 1:50</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-γH2AX (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 2577;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2118010">AB_2118010</ext-link></td><td align="left" valign="bottom">IHC 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-COX4 (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">Cat#:11242–1-AP;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2085278">AB_2085278</ext-link></td><td align="left" valign="bottom">IF1:3000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GLUT1 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#:73015</td><td align="left" valign="bottom">IHC 1:600</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TOMM20 (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">Cat#: 73015;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2207530">AB_2207530</ext-link></td><td align="left" valign="bottom">IF 1:4000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TFAM (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab307302</td><td align="left" valign="bottom">IF 1:3000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PARL (rabbit polyclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16839884/">16839884</ext-link></td><td align="left" valign="bottom">Cat#: N/A</td><td align="left" valign="bottom">WB 1/1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-actin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: A5441;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_476744">AB_476744</ext-link></td><td align="left" valign="bottom">WB 1:200,000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HSP60 (mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#: 611562;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_399008">AB_399008</ext-link></td><td align="left" valign="bottom">WB 1:50,000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ATP5B (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab14730;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_301438">AB_301438</ext-link></td><td align="left" valign="bottom">WB 1:50,000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TOMM20 (rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat#: sc-11415;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2207533">AB_2207533</ext-link></td><td align="left" valign="bottom">WB 1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PINK1 (rabbit polyclonal)</td><td align="left" valign="bottom">Cayman</td><td align="left" valign="bottom">Cat#: 10006283;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10098326">AB_10098326</ext-link></td><td align="left" valign="bottom">WB 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PGAM5 (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: HPA036979;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10960559">AB_10960559</ext-link></td><td align="left" valign="bottom">WB 1:250</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TTC19 (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: HPA052380;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2681806">AB_2681806</ext-link></td><td align="left" valign="bottom">WB 1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CLPB (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">Cat#: 15743-1-AP;<break/> RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2847900">AB_2847900</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-STARD7 (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">Cat#: 15689-1-AP;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2197820">AB_2197820</ext-link></td><td align="left" valign="bottom">WB 1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-DIABLO (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 15108;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2798711">AB_2798711</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GPX4 (mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat#: MAB5457;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2232542">AB_2232542</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GPX4 (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat#: sc-166570;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2112427">AB_2112427</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HNE (mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat#: 198960;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_664165">AB_664165</ext-link></td><td align="left" valign="bottom">WB 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-citrate synthase (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab96600;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10678258">AB_10678258</ext-link></td><td align="left" valign="bottom">WB 1:1000</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism software</td><td align="left" valign="bottom">GraphPad Prism <break/>(<ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015807">SCR_015807</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software</td><td align="left" valign="bottom">ImageJ software</td><td align="left" valign="bottom">ImageJ <break/>(<ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals and husbandry</title><p>Mice with full knockout germline deletion of <italic>Parl</italic> (<italic>Parl<sup>-/-</sup></italic>) (MGI:3693645), <italic>Pgam5</italic> (<italic>Pgam5<sup>-/-</sup></italic>) (MGI:5882561), <italic>Pink1</italic> (<italic>Pink1<sup>-/-</sup></italic>) (MGI:5436308), <italic>Ttc19</italic> (<italic>Ttc19<sup>-/-</sup></italic>) (MGI:6276545), and conditional <italic>Parl</italic> ablation under the Nestin promoter (<italic>Parl <sup>L/L</sup>::Nes<sup>Cre</sup></italic>) (MGI:3526574, MGI:2176173) have been generated as previously described (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>; <xref ref-type="bibr" rid="bib17">Cipolat et al., 2006</xref>). All mutant mouse lines were maintained on a C57BL/6J background. Mice were kept in a SPF facility and multiply housed in filter top polycarbonated cages enriched with wood‐wool and shavings as bedding. Standard rodent diet and acidified tap water were provided <italic>ad libitum</italic>. Animal rooms were maintained at 22°C ± 2°C with a 45 and 70% relative humidity range, 50 air changes per hour, and 12-hr light/dark cycles. Mice were included in a health-monitoring program developed in accordance with the guidelines of the Federation of European Laboratory Animal Science Associations (FELASA). All experiments were approved by the Ethical Committee on Animal Experimenting of the University of Leuven (IACUC protocol #072/2015) and the French Ministry (DUO-OGM 5769 3/2019).</p></sec><sec id="s4-2"><title>Pathological and immunohistochemical examination</title><p>Testes harvested from postpubertal mutant mice and WT matched controls were immersion-fixed in 10% neutral buffered formalin for 24–48 hr at room temperature (RT). Samples were then routinely processed for paraffin embedding, sectioned at 5 µm, and stained with hematoxylin and eosin (HE) for histopathological assessment. For immunohistochemistry (IHC), 5-µm-thick paraffin sections were mounted on ProbeOn slides (Thermo Fisher Scientific #15-188-51). Chromogenic immunohistochemistry (IHC) and multiplex immunofluorescence (IF) were performed as described elsewhere (<xref ref-type="bibr" rid="bib86">Tarrant et al., 2021</xref>) using a Leica BOND RXm automated platform combined with the Bond Polymer Refine Detection kit (Leica #DS9800) for IHC or the OPAL Automation Multiplex IHC Detection Kit (Akoya Biosciences NEL830001KT) implemented onto a Leica BOND Research Detection System (DS9455) for IF. Briefly, after dewaxing and rehydration, sections were pretreated with the epitope retrieval BOND ER2 high pH buffer (Leica #AR9640) for 20 min at 98°C. Endogenous peroxidase was inactivated with 3% H<sub>2</sub>O<sub>2</sub> for 10 min at RT. Nonspecific tissue–antibody interactions were blocked by incubating the sections for 30 min at RT with Leica PowerVision IHC/ISH Super Blocking solution (PV6122) for IHC or with the Akoya Biosciences Opal Antibody Diluent/Block solution (ARD1001EA) for IF. The same blocking solution also served as diluent for the primary antibodies. Primary antibodies were incubated on the sections for 45 min at RT. A biotin-free polymeric detection system consisting of HRP conjugated anti-rabbit IgG was then applied for 25 min at RT. For IHC, immunoreactivity was then revealed with the diaminobenzidine (DAB) chromogen reaction. Tissue sections were finally counterstained in hematoxylin, dehydrated in an ethanol series, cleared in xylene, and permanently mounted with a resinous mounting medium (Thermo Scientific ClearVue coverslipper). For IF, the sections were finally incubated with the Akoya Biosciences TSA reagents Opal 520 (OP-1001), 570 (OP-1002), and 690 (OP-1003) (working concentration 1/150) for 10 min at RTs followed by Spectral DAPI nuclear counterstain (Akoya Biosciences FP1490) and mounting with Fluoromount-G (SouthernBiotech 100-01). Negative controls were obtained by replacement of the primary antibodies with irrelevant isotype-matched rabbit antibodies. HE and IHC-stained slides were evaluated by two board-certified veterinary pathologists (ER and CAA) with extensive expertise in mouse pathology. Staging of the seminiferous tubules was performed according to well-established morphological criteria (<xref ref-type="bibr" rid="bib2">Ahmed and de Rooij, 2009</xref>; <xref ref-type="bibr" rid="bib60">Meistrich and Hess, 2013</xref>). The Aperio Versa 200 instrument was used for image acquisition. Digital image analysis for cell count and morphometry of seminiferous tubules as well as for normalized quantification of marker expression within the SCP-1-positive spermatocyte population was performed using FIJI/ImageJ open-source software (<xref ref-type="bibr" rid="bib72">Schroeder et al., 2021</xref>; <xref ref-type="bibr" rid="bib6">Arena et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Schindelin et al., 2012</xref>). Values for the normalized quantification correspond to the average positive area per spermatocyte and are expressed in um (<xref ref-type="bibr" rid="bib4">Aitken et al., 2022</xref>).</p></sec><sec id="s4-3"><title>Immunoblot analysis</title><p>Total testis lysates were prepared by homogenization with a glass-to-glass potter homogenizer on ice in 20 mM HEPES, 100 NaCl, pH 7.4, supplemented with protease and phosphate inhibitors (ROCHE). The lysate was then transferred to a fresh tube, supplemented with Triton- X 1%, SDS 0.1%, and passed several times through a 26-gauge syringe. The samples were then centrifuged at 20,000 × <italic>g</italic> for 15 min at 4°C to remove insoluble material. Tissue extracts or enriched mitochondrial membranes were separated in reducing and denaturing conditions in NuPage gels (Invitrogen). Proteins were transferred to PVDF 0.45 µm membranes, blocked with milk 5% TRIS-buffered saline, Tween-20 0.1% (TTBS), and incubated with the indicated primary antibodies, washed in TTBS incubated for 1 hr at RT with horseradish peroxidase conjugated secondary antibodies in 5% milk-TTBS or Alexa Fluor conjugated secondary antibodies. Proteins were identified by chemiluminescence or by fluorescence according to the type of secondary antibody. A PARL carboxy-terminal antibody was generated in house as previously reported (<xref ref-type="bibr" rid="bib17">Cipolat et al., 2006</xref>).</p></sec><sec id="s4-4"><title>Subcellular fractionation methods</title><p>To prepare testis-enriched mitochondrial fractions for western blotting or blue native gel electrophoresis, freshly collected testis was homogenized with a motor-driven Teflon pestle set at 800 rpm in a glass potter containing ice-cold 20 mM HEPES, 225 mM sucrose, 75 mM mannitol, 1 mM EGTA pH 7.4, on ice. For mitochondrial respiration experiments, fresh testis was homogenized manually with a Teflon pestle in ice-cold 20 mM HEPES, 225 mM sucrose, 75 mM mannitol, 1 mM EGTA pH 7.4, on ice, then gently passed through a 22-gauge syringe. The homogenate was centrifuged at 700 × <italic>g</italic> for 10 min at 4°C to remove nuclei and unbroken debris. The supernatant (tissue homogenate) was then centrifuged at 10,000 × <italic>g</italic> for 10 min at 4°C to pellet mitochondrial enriched mitochondrial membranes. To prepare liver enriched mitochondrial fractions, freshly collected liver was thoroughly rinsed in homogenization buffer, then homogenized with a motor-driven Teflon pestle set at 800 rpm in a glass potter containing ice-cold 20 mM HEPES, 225 mM sucrose, 75 mM mannitol, 1 mM EGTA pH 7.4, on ice. The homogenate was centrifuged at 1000 × <italic>g</italic> for 10 min at 4°C to remove nuclei and unbroken debris. The supernatant (tissue homogenate) was then centrifuged at 6000 × <italic>g</italic> for 10 min at 4°C. Brain mitochondria were purified according to Sims’ method (<xref ref-type="bibr" rid="bib78">Sims and Anderson, 2008</xref>).</p></sec><sec id="s4-5"><title>Blue native gel electrophoresis</title><p>Blue native gel electrophoresis of digitonin-solubilized mitochondria was performed as described (<xref ref-type="bibr" rid="bib40">Jha et al., 2016</xref>). Then, 100 µg isolated mitochondria were solubilized with 600 µg digitonin in Invitrogen Native Page sample buffer on ice for 20 min, then centrifuged at 20,000 × <italic>g</italic> for 20 min at 4°C. 0.75% Coomassie G-250 was added to supernatants, which were loaded on a 3–12% gradient Invitrogen Native Page gel according to the instructions. After electrophoresis, mitochondrial complexes and super complexes were visualized by protein staining with InstantBlue Coomassie Protein Stain (ISB1L) (Abcam ab119211).</p></sec><sec id="s4-6"><title>High-resolution respirometry</title><p>Mitochondrial respiration in testis mitochondria respiration was measured in Miro6 Buffer (<xref ref-type="bibr" rid="bib25">Fasching et al., 2016</xref>) (20 mM HEPES, 110 mM sucrose, 10 mM KH<sub>2</sub>PO<sub>4</sub>, 20 mM taurine, 60 mM lactobionic acid, 3 mM MgCl<sub>2</sub>, 0.5 EGTA, pH 7.1, 1 mg/ml fatty acid-free BSA, catalase 280 U/ml) at 37°C as previously described (<xref ref-type="bibr" rid="bib66">Pesta and Gnaiger, 2012</xref>; <xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). When needed H<sub>2</sub>O<sub>2</sub> was added to reoxygenate the chambers by catalase mediated O<sub>2</sub> generation. Then, 150 µg of mitochondrial-enriched membranes were loaded into the Oroboros 2K oxygraph. A typical experiment is illustrated in <xref ref-type="fig" rid="fig4">Figure 4D</xref>. Oxygen consumption rates were measured before and after addition of the following sequence of substrates and specific inhibitors: (1) 2.5 mM pyruvate, 10 mM glutamate, and 1 mM malate to measure complex I-driven leak respiration (CI leak); (2) 2.5 mM ADP to determine complex I-driven phosphorylating respiration (CI OXPHOS). (3) 5 mM succinate to determine the phosphorylating respiration driven by simultaneous activation of complex I and II (CI + II OXPHOS); (4) titrating concentrations of the mitochondrial uncoupler CCCP to reach the maximal uncoupled respiration (CI + II electron transfer capacity, ET); (5) 200 nM rotenone to fully inhibit complex I-driven respiration and measure complex II-driven uncoupled respiration (CII electron transfer capacity, CII ET); (6) 0.5 µM antimycin A to block mitochondrial respiration at the level of complex III. Residual oxygen consumption was always negligible. (7) 2 mM ascorbate, 0.5 mM TMPD to measure cytochrome <italic>c</italic> oxidase (CIV)-driven respiration; (8) 125 µg/ml cytochrome <italic>c</italic> to evaluate mitochondrial outer membrane integrity and (9) 500 µM potassium cyanide (KCN) to specifically block cytochrome <italic>c</italic> oxidase activity and measure residual background oxygen consumption caused by chemical reaction between ascorbate and TMPD. Cytochrome <italic>c</italic> oxidase-driven respiration was calculated as the cyanide-sensitive oxygen consumption.</p></sec><sec id="s4-7"><title>CoQ analysis</title><p>CoQ content and the ratio of the reduced vs. oxidized forms were measured as previously described (<xref ref-type="bibr" rid="bib68">Rodríguez-Aguilera et al., 2017</xref>).</p></sec><sec id="s4-8"><title>mtDNA copy number quantification</title><p>For mtDNA quantification, total DNA was isolated from 20 to 30 mg of testis tissues by using a DNeasy Blood and tissues kit (QIAGEN). qPCRs were performed in triplicate in 96-well reaction plates (Applied Biosystems). Each reaction (final volume 10 µl) contained 25 ng DNA, 5 µl of Power SYBR-Green PCR Master Mix (Applied Biosystems), and 0.5 µM of each forward and reverse primer. COX1, mitochondrial encoded gene, was amplified and β2 microglobulin (β2 m), nuclear encoded gene, was used as a normalizing control. Fold changes in mtDNA amount were calculated with the ΔΔCt method. The employed primers sequences were Cox1-Mus-F: <named-content content-type="sequence">TTTTCAGGCTTCACCCTAGATGA</named-content>, Cox1-Mus-R: <named-content content-type="sequence">CCTACGAATATGATGGCGAAGTG</named-content>, B2m-Mus-F: <named-content content-type="sequence">ATGGGAAGCCGAACATACTG</named-content>, B2M-Mus-R:<named-content content-type="sequence">CAGTCTCAGTGGGGGTGAAT.</named-content></p></sec><sec id="s4-9"><title>Electron microscopy</title><p>Testes of the indicated genotype were collected and immediately fixed with 2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 M cacodylate buffer pH 7.4. Tissue was stored overnight at 4°C in the fixative solution, washed in 0.1 M cacodylate buffer, and post-fixed for 2 hr at RT with 1% OsO<sub>4</sub>, 1.5% K<sub>4</sub>Fe(CN)<sub>6</sub> in 0.1 M cacodylate buffer. Sections were rinsed, stained with 3% uranyl acetate for 1 hr at 4°C, and dehydrated in graded ethanol concentrations and propyleneoxide, followed by embedding in Epon Resin. Resin blocks were sectioned on a ultramicrotome. Post-staining was performed with 3% uranyl acetate followed by lead citrate staining. Semithin sections were collected on slides and stained with 1% Toluidine blue solution (Sigma-Aldrich). Ultrathin sections (60 nm) were mounted on copper grids and imaged using a JEOL transmission electron microscope.</p></sec><sec id="s4-10"><title>Cultured cells</title><p>Immortalized mouse embryonic fibroblasts (MEFs) derived from WT and <italic>Parl<sup>-/-</sup></italic> male mice were cultured in Dulbecco’s modified Eagle’s medium/F-12 (Gibco) containing 10% fetal bovine serum (Gibco). At 30–40% confluence, the MEFs were transduced using a replication-defective recombinant retroviral expression system (Clontech) with either wild-type (<italic>Parl</italic> WT) or catalytic inactive <italic>Parl S275A</italic> as previously described (<xref ref-type="bibr" rid="bib80">Spinazzi et al., 2019</xref>). Cell lines stably expressing the desired proteins were selected based on their acquired resistance to 5 µg/ml puromycin. Cells were regularly tested to rule out Mycoplasma contamination.</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Numerical data are expressed and illustrated in all graph bars as mean ± SD from biological replicates. No statistical tests were used to predetermine sample size. Replicates numbers were decided from experience of the techniques performed and practical considerations. Two-sided Student’s <italic>t</italic>-test was used to compare differences of all quantitative variables between two groups, and Fisher’s exact test was used for the analysis of contingency tables to compare the frequency distribution of ultrastructural abnormalities in two groups. Significance was calculated using GraphPad. Differences were considered statistically significant for p≤0.05. No data were excluded.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Mice were included in a health-monitoring program developed in accordance with guidelines of the Federation of European Laboratory Animal Science Associations (FELASA). All experiments were approved by the Ethical Committee on Animal Experimenting of the University of Leuven (IACUC protocol #072/2015) and by the French Ministry (DUO-OGM 5769 29/3/2019).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-84710-transrepform1-v3.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file. Source data files have been included.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was supported by the University of Pennsylvania URF research funding to ER (URF Fall 19-0914) and AFM-Telethon to MS (23019). MS is recipient of an INSERM translational research grant (CIHU INSERM). The authors affiliated with the Penn Vet Comparative Pathology Core are partially subsidized by the Abramson Cancer Center Support Grant (P30 CA016520); the Aperio Versa 200 scanner used for imaging was acquired through an NIH Shared Instrumentation Grant (S10 OD023465-01A1); the Leica BOND RXm instrument used for IHC was acquired through the Penn Vet IIZD Core pilot grant opportunity 2022. We are profoundly grateful to Prof. Bart De Strooper, KU Leuven, for his support and for the generous gift of all mouse strains used in this project. We thank Prof. Jeremy Wang, University of Pennsylvania, for his insightful comments as well as Dr. Cristina Ugalde, University Hospital of Madrid, for her feedback on blue-native electrophoresis results.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Panner Selvam</surname><given-names>MK</given-names></name><name><surname>Baskaran</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteomic analyses of human sperm cells: understanding the role of proteins and molecular pathways affecting male reproductive health</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>1621</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21051621</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>EA</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Staging of mouse seminiferous tubule cross-sections</article-title><source>Methods in Molecular Biology</source><volume>558</volume><fpage>263</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1007/978-1-60761-103-5_16</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahola</surname><given-names>S</given-names></name><name><surname>Rivera Mejías</surname><given-names>P</given-names></name><name><surname>Hermans</surname><given-names>S</given-names></name><name><surname>Chandragiri</surname><given-names>S</given-names></name><name><surname>Giavalisco</surname><given-names>P</given-names></name><name><surname>Nolte</surname><given-names>H</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy</article-title><source>Cell Metabolism</source><volume>34</volume><fpage>1875</fpage><lpage>1891</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2022.08.017</pub-id><pub-id pub-id-type="pmid">36113464</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitken</surname><given-names>RJ</given-names></name><name><surname>Drevet</surname><given-names>JR</given-names></name><name><surname>Moazamian</surname><given-names>A</given-names></name><name><surname>Gharagozloo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Male infertility and oxidative stress: a focus on the underlying mechanisms</article-title><source>Antioxidants</source><volume>11</volume><elocation-id>306</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11020306</pub-id><pub-id pub-id-type="pmid">35204189</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand-Ivell</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Insights into the development of the adult leydig cell lineage from stem leydig cells</article-title><source>Frontiers in Physiology</source><volume>1</volume><elocation-id>430</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00430</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arena</surname><given-names>ET</given-names></name><name><surname>Rueden</surname><given-names>CT</given-names></name><name><surname>Hiner</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Quantitating the cell: turning images into numbers with ImageJ</article-title><source>Wiley Interdisciplinary Reviews. Developmental Biology</source><volume>6</volume><elocation-id>260</elocation-id><pub-id pub-id-type="doi">10.1002/wdev.260</pub-id><pub-id pub-id-type="pmid">27911038</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atwal</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mutations in the Complex III Assembly Factor Tetratricopeptide 19 Gene TTC19 Are a Rare Cause of Leigh Syndrome</article-title><source>JIMD Reports</source><volume>14</volume><fpage>43</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/8904_2013_282</pub-id><pub-id pub-id-type="pmid">24368687</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bersuker</surname><given-names>K</given-names></name><name><surname>Hendricks</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Magtanong</surname><given-names>L</given-names></name><name><surname>Ford</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>PH</given-names></name><name><surname>Roberts</surname><given-names>MA</given-names></name><name><surname>Tong</surname><given-names>B</given-names></name><name><surname>Maimone</surname><given-names>TJ</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Bassik</surname><given-names>MC</given-names></name><name><surname>Nomura</surname><given-names>DK</given-names></name><name><surname>Dixon</surname><given-names>SJ</given-names></name><name><surname>Olzmann</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis</article-title><source>Nature</source><volume>575</volume><fpage>688</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1705-2</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beumer</surname><given-names>TL</given-names></name><name><surname>Roepers-Gajadien</surname><given-names>HL</given-names></name><name><surname>Gademan</surname><given-names>IS</given-names></name><name><surname>van Buul</surname><given-names>PP</given-names></name><name><surname>Gil-Gomez</surname><given-names>G</given-names></name><name><surname>Rutgers</surname><given-names>DH</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The role of the tumor suppressor p53 in spermatogenesis</article-title><source>Cell Death and Differentiation</source><volume>5</volume><fpage>669</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400396</pub-id><pub-id pub-id-type="pmid">10200522</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>J</given-names></name><name><surname>Bunting</surname><given-names>L</given-names></name><name><surname>Collins</surname><given-names>JA</given-names></name><name><surname>Nygren</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reply: International estimates on infertility prevalence and treatment seeking: potential need and demand for medical care</article-title><source>Human Reproduction</source><volume>24</volume><fpage>2380</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1093/humrep/dep218</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottani</surname><given-names>E</given-names></name><name><surname>Cerutti</surname><given-names>R</given-names></name><name><surname>Harbour</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex III</article-title><source>Molecular Cell</source><volume>67</volume><fpage>96</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.001</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>JV</given-names></name><name><surname>Lim</surname><given-names>CH</given-names></name><name><surname>Jorgensen</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>SP</given-names></name><name><surname>Terada</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells</article-title><source>Reproduction</source><volume>138</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1530/REP-09-0201</pub-id><pub-id pub-id-type="pmid">19556438</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadalbert</surname><given-names>LC</given-names></name><name><surname>Ghaffar</surname><given-names>FN</given-names></name><name><surname>Stevenson</surname><given-names>D</given-names></name><name><surname>Bryson</surname><given-names>S</given-names></name><name><surname>Vaz</surname><given-names>FM</given-names></name><name><surname>Gottlieb</surname><given-names>E</given-names></name><name><surname>Strathdee</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mouse tafazzin is required for male germ cell meiosis and spermatogenesis</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0131066</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0131066</pub-id><pub-id pub-id-type="pmid">26114544</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>MV</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Pinkert</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial biology in reproduction</article-title><source>Reproductive Medicine and Biology</source><volume>10</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1007/s12522-011-0101-x</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>BA</given-names></name><name><surname>Tobe</surname><given-names>R</given-names></name><name><surname>Yefremova</surname><given-names>E</given-names></name><name><surname>Tsuji</surname><given-names>PA</given-names></name><name><surname>Hoffmann</surname><given-names>VJ</given-names></name><name><surname>Schweizer</surname><given-names>U</given-names></name><name><surname>Gladyshev</surname><given-names>VN</given-names></name><name><surname>Hatfield</surname><given-names>DL</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration</article-title><source>Redox Biology</source><volume>9</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2016.05.003</pub-id><pub-id pub-id-type="pmid">27262435</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Comish</surname><given-names>PB</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characteristics and biomarkers of ferroptosis</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>637162</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.637162</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipolat</surname><given-names>S</given-names></name><name><surname>Rudka</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name><name><surname>Serneels</surname><given-names>L</given-names></name><name><surname>Craessaerts</surname><given-names>K</given-names></name><name><surname>Metzger</surname><given-names>K</given-names></name><name><surname>Frezza</surname><given-names>C</given-names></name><name><surname>Annaert</surname><given-names>W</given-names></name><name><surname>D’Adamio</surname><given-names>L</given-names></name><name><surname>Derks</surname><given-names>C</given-names></name><name><surname>Dejaegere</surname><given-names>T</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>D’Hooge</surname><given-names>R</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling</article-title><source>Cell</source><volume>126</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.021</pub-id><pub-id pub-id-type="pmid">16839884</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civitarese</surname><given-names>AE</given-names></name><name><surname>MacLean</surname><given-names>PS</given-names></name><name><surname>Carling</surname><given-names>S</given-names></name><name><surname>Kerr-Bayles</surname><given-names>L</given-names></name><name><surname>McMillan</surname><given-names>RP</given-names></name><name><surname>Pierce</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>TC</given-names></name><name><surname>Moro</surname><given-names>C</given-names></name><name><surname>Finlayson</surname><given-names>J</given-names></name><name><surname>Lefort</surname><given-names>N</given-names></name><name><surname>Newgard</surname><given-names>CB</given-names></name><name><surname>Mandarino</surname><given-names>L</given-names></name><name><surname>Cefalu</surname><given-names>W</given-names></name><name><surname>Walder</surname><given-names>K</given-names></name><name><surname>Collier</surname><given-names>GR</given-names></name><name><surname>Hulver</surname><given-names>MW</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL</article-title><source>Cell Metabolism</source><volume>11</volume><fpage>412</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2010.04.004</pub-id><pub-id pub-id-type="pmid">20444421</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidoff</surname><given-names>MS</given-names></name><name><surname>Middendorff</surname><given-names>R</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name><name><surname>Riethmacher</surname><given-names>D</given-names></name><name><surname>Holstein</surname><given-names>AF</given-names></name><name><surname>Müller</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Progenitor cells of the testosterone-producing Leydig cells revealed</article-title><source>The Journal of Cell Biology</source><volume>167</volume><fpage>935</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1083/jcb.200409107</pub-id><pub-id pub-id-type="pmid">15569711</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Dodson</surname><given-names>MW</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The Parkinson’s disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>105</volume><fpage>14503</fpage><lpage>14508</lpage><pub-id pub-id-type="doi">10.1073/pnas.0803998105</pub-id><pub-id pub-id-type="pmid">18799731</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshwal</surname><given-names>S</given-names></name><name><surname>Onishi</surname><given-names>M</given-names></name><name><surname>Tatsuta</surname><given-names>T</given-names></name><name><surname>Bartsch</surname><given-names>T</given-names></name><name><surname>Cors</surname><given-names>E</given-names></name><name><surname>Ried</surname><given-names>K</given-names></name><name><surname>Lemke</surname><given-names>K</given-names></name><name><surname>Nolte</surname><given-names>H</given-names></name><name><surname>Giavalisco</surname><given-names>P</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7</article-title><source>Nature Cell Biology</source><volume>25</volume><fpage>246</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-01071-y</pub-id><pub-id pub-id-type="pmid">36658222</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogan</surname><given-names>SA</given-names></name><name><surname>Pujol</surname><given-names>C</given-names></name><name><surname>Maiti</surname><given-names>P</given-names></name><name><surname>Kukat</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Hermans</surname><given-names>S</given-names></name><name><surname>Senft</surname><given-names>K</given-names></name><name><surname>Wibom</surname><given-names>R</given-names></name><name><surname>Rugarli</surname><given-names>EI</given-names></name><name><surname>Trifunovic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart</article-title><source>Cell Metabolism</source><volume>19</volume><fpage>458</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.02.004</pub-id><pub-id pub-id-type="pmid">24606902</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>S</given-names></name><name><surname>Freitas</surname><given-names>FP</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Aldrovandi</surname><given-names>M</given-names></name><name><surname>da Silva</surname><given-names>MC</given-names></name><name><surname>Ingold</surname><given-names>I</given-names></name><name><surname>Goya Grocin</surname><given-names>A</given-names></name><name><surname>Xavier da Silva</surname><given-names>TN</given-names></name><name><surname>Panzilius</surname><given-names>E</given-names></name><name><surname>Scheel</surname><given-names>CH</given-names></name><name><surname>Mourão</surname><given-names>A</given-names></name><name><surname>Buday</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Wanninger</surname><given-names>J</given-names></name><name><surname>Vignane</surname><given-names>T</given-names></name><name><surname>Mohana</surname><given-names>V</given-names></name><name><surname>Rehberg</surname><given-names>M</given-names></name><name><surname>Flatley</surname><given-names>A</given-names></name><name><surname>Schepers</surname><given-names>A</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Sauer</surname><given-names>M</given-names></name><name><surname>Sattler</surname><given-names>M</given-names></name><name><surname>Tate</surname><given-names>EW</given-names></name><name><surname>Schmitz</surname><given-names>W</given-names></name><name><surname>Schulze</surname><given-names>A</given-names></name><name><surname>O’Donnell</surname><given-names>V</given-names></name><name><surname>Proneth</surname><given-names>B</given-names></name><name><surname>Popowicz</surname><given-names>GM</given-names></name><name><surname>Pratt</surname><given-names>DA</given-names></name><name><surname>Angeli</surname><given-names>JPF</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>FSP1 is a glutathione-independent ferroptosis suppressor</article-title><source>Nature</source><volume>575</volume><fpage>693</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1707-0</pub-id><pub-id pub-id-type="pmid">31634899</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekstrand</surname><given-names>MI</given-names></name><name><surname>Falkenberg</surname><given-names>M</given-names></name><name><surname>Rantanen</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>CB</given-names></name><name><surname>Gaspari</surname><given-names>M</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Rustin</surname><given-names>P</given-names></name><name><surname>Gustafsson</surname><given-names>CM</given-names></name><name><surname>Larsson</surname><given-names>N-G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mitochondrial transcription factor A regulates mtDNA copy number in mammals</article-title><source>Human Molecular Genetics</source><volume>13</volume><fpage>935</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddh109</pub-id><pub-id pub-id-type="pmid">15016765</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasching</surname><given-names>M</given-names></name><name><surname>Renner-sattler</surname><given-names>K</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial Respiration Medium - MiR06</article-title><source>Mitochondrial Physiology Network</source><volume>14</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Schorpp</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Yozwiak</surname><given-names>CE</given-names></name><name><surname>Hoffstrom</surname><given-names>BG</given-names></name><name><surname>Decker</surname><given-names>AM</given-names></name><name><surname>Rajbhandari</surname><given-names>P</given-names></name><name><surname>Stokes</surname><given-names>ME</given-names></name><name><surname>Bender</surname><given-names>HG</given-names></name><name><surname>Csuka</surname><given-names>JM</given-names></name><name><surname>Upadhyayula</surname><given-names>PS</given-names></name><name><surname>Canoll</surname><given-names>P</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Soni</surname><given-names>RK</given-names></name><name><surname>Hadian</surname><given-names>K</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transferrin receptor is a specific ferroptosis marker</article-title><source>Cell Reports</source><volume>30</volume><fpage>3411</fpage><lpage>3423</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.049</pub-id><pub-id pub-id-type="pmid">32160546</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foresta</surname><given-names>C</given-names></name><name><surname>Flohé</surname><given-names>L</given-names></name><name><surname>Garolla</surname><given-names>A</given-names></name><name><surname>Roveri</surname><given-names>A</given-names></name><name><surname>Ursini</surname><given-names>F</given-names></name><name><surname>Maiorino</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase</article-title><source>Biology of Reproduction</source><volume>67</volume><fpage>967</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.102.003822</pub-id><pub-id pub-id-type="pmid">12193409</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsström</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>CB</given-names></name><name><surname>Carroll</surname><given-names>CJ</given-names></name><name><surname>Kuronen</surname><given-names>M</given-names></name><name><surname>Pirinen</surname><given-names>E</given-names></name><name><surname>Pradhan</surname><given-names>S</given-names></name><name><surname>Marmyleva</surname><given-names>A</given-names></name><name><surname>Auranen</surname><given-names>M</given-names></name><name><surname>Kleine</surname><given-names>I-M</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Roivainen</surname><given-names>A</given-names></name><name><surname>Marjamäki</surname><given-names>P</given-names></name><name><surname>Liljenbäck</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Battersby</surname><given-names>BJ</given-names></name><name><surname>Richter</surname><given-names>U</given-names></name><name><surname>Velagapudi</surname><given-names>V</given-names></name><name><surname>Nikkanen</surname><given-names>J</given-names></name><name><surname>Euro</surname><given-names>L</given-names></name><name><surname>Suomalainen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions</article-title><source>Cell Metabolism</source><volume>30</volume><fpage>1040</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.08.019</pub-id><pub-id pub-id-type="pmid">31523008</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedmann Angeli</surname><given-names>JP</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Proneth</surname><given-names>B</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Hammond</surname><given-names>VJ</given-names></name><name><surname>Herbach</surname><given-names>N</given-names></name><name><surname>Aichler</surname><given-names>M</given-names></name><name><surname>Walch</surname><given-names>A</given-names></name><name><surname>Eggenhofer</surname><given-names>E</given-names></name><name><surname>Basavarajappa</surname><given-names>D</given-names></name><name><surname>Rådmark</surname><given-names>O</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Seibt</surname><given-names>T</given-names></name><name><surname>Beck</surname><given-names>H</given-names></name><name><surname>Neff</surname><given-names>F</given-names></name><name><surname>Esposito</surname><given-names>I</given-names></name><name><surname>Wanke</surname><given-names>R</given-names></name><name><surname>Förster</surname><given-names>H</given-names></name><name><surname>Yefremova</surname><given-names>O</given-names></name><name><surname>Heinrichmeyer</surname><given-names>M</given-names></name><name><surname>Bornkamm</surname><given-names>GW</given-names></name><name><surname>Geissler</surname><given-names>EK</given-names></name><name><surname>Thomas</surname><given-names>SB</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name><name><surname>O’Donnell</surname><given-names>VB</given-names></name><name><surname>Kagan</surname><given-names>VE</given-names></name><name><surname>Schick</surname><given-names>JA</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/ncb3064</pub-id><pub-id pub-id-type="pmid">25402683</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Minikes</surname><given-names>AM</given-names></name><name><surname>Monian</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Role of mitochondria in ferroptosis</article-title><source>Molecular Cell</source><volume>73</volume><fpage>354</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.10.042</pub-id><pub-id pub-id-type="pmid">30581146</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transferrin receptor (TFRC) is essential for meiotic progression during mouse spermatogenesis</article-title><source>Zygote</source><volume>29</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1017/S0967199420000659</pub-id><pub-id pub-id-type="pmid">33323153</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gispert</surname><given-names>S</given-names></name><name><surname>Parganlija</surname><given-names>D</given-names></name><name><surname>Klinkenberg</surname><given-names>M</given-names></name><name><surname>Dröse</surname><given-names>S</given-names></name><name><surname>Wittig</surname><given-names>I</given-names></name><name><surname>Mittelbronn</surname><given-names>M</given-names></name><name><surname>Grzmil</surname><given-names>P</given-names></name><name><surname>Koob</surname><given-names>S</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Büchel</surname><given-names>F</given-names></name><name><surname>Adler</surname><given-names>T</given-names></name><name><surname>Hrabé de Angelis</surname><given-names>M</given-names></name><name><surname>Busch</surname><given-names>DH</given-names></name><name><surname>Zell</surname><given-names>A</given-names></name><name><surname>Reichert</surname><given-names>AS</given-names></name><name><surname>Brandt</surname><given-names>U</given-names></name><name><surname>Osiewacz</surname><given-names>HD</given-names></name><name><surname>Jendrach</surname><given-names>M</given-names></name><name><surname>Auburger</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>4871</fpage><lpage>4887</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt338</pub-id><pub-id pub-id-type="pmid">23851121</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godeas</surname><given-names>C</given-names></name><name><surname>Tramer</surname><given-names>F</given-names></name><name><surname>Micali</surname><given-names>F</given-names></name><name><surname>Soranzo</surname><given-names>M</given-names></name><name><surname>Sandri</surname><given-names>G</given-names></name><name><surname>Panfili</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Distribution and possible novel role of phospholipid hydroperoxide glutathione peroxidase in rat epididymal spermatozoa</article-title><source>Biology of Reproduction</source><volume>57</volume><fpage>1502</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1095/biolreprod57.6.1502</pub-id><pub-id pub-id-type="pmid">9408261</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueguen</surname><given-names>N</given-names></name><name><surname>Baris</surname><given-names>O</given-names></name><name><surname>Lenaers</surname><given-names>G</given-names></name><name><surname>Reynier</surname><given-names>P</given-names></name><name><surname>Spinazzi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Secondary coenzyme Q deficiency in neurological disorders</article-title><source>Free Radical Biology &amp; Medicine</source><volume>165</volume><fpage>203</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2021.01.017</pub-id><pub-id pub-id-type="pmid">33450382</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cui</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Meng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Reduction of SLC7A11 and GPX4 Contributing to Ferroptosis in Sperm from Asthenozoospermia Individuals</article-title><source>Reproductive Sciences</source><volume>30</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/s43032-022-01004-y</pub-id><pub-id pub-id-type="pmid">35729458</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatunic</surname><given-names>M</given-names></name><name><surname>Stapleton</surname><given-names>M</given-names></name><name><surname>Hand</surname><given-names>E</given-names></name><name><surname>DeLong</surname><given-names>C</given-names></name><name><surname>Crowley</surname><given-names>VEF</given-names></name><name><surname>Nolan</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The Leu262Val polymorphism of presenilin associated rhomboid like protein (PARL) is associated with earlier onset of type 2 diabetes and increased urinary microalbumin creatinine ratio in an Irish case-control population</article-title><source>Diabetes Research and Clinical Practice</source><volume>83</volume><fpage>316</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2008.12.004</pub-id><pub-id pub-id-type="pmid">19185381</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Ishizaka</surname><given-names>K</given-names></name><name><surname>Ichinose</surname><given-names>S</given-names></name><name><surname>Oshima</surname><given-names>H</given-names></name><name><surname>Okayasu</surname><given-names>I</given-names></name><name><surname>Emoto</surname><given-names>K</given-names></name><name><surname>Umeda</surname><given-names>M</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Failure of the expression of phospholipid hydroperoxide glutathione peroxidase in the spermatozoa of human infertile males</article-title><source>Biology of Reproduction</source><volume>64</volume><fpage>674</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1095/biolreprod64.2.674</pub-id><pub-id pub-id-type="pmid">11159372</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Hakkaku</surname><given-names>N</given-names></name><name><surname>Iwamoto</surname><given-names>R</given-names></name><name><surname>Suzuki</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Tajima</surname><given-names>Y</given-names></name><name><surname>Konishi</surname><given-names>K</given-names></name><name><surname>Minami</surname><given-names>S</given-names></name><name><surname>Ichinose</surname><given-names>S</given-names></name><name><surname>Ishizaka</surname><given-names>K</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Arata</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Naito</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Depletion of selenoprotein GPx4 in spermatocytes causes male infertility in mice</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>32522</fpage><lpage>32532</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.016139</pub-id><pub-id pub-id-type="pmid">19783653</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Istikharah</surname><given-names>R</given-names></name><name><surname>Tun</surname><given-names>AW</given-names></name><name><surname>Kaewsutthi</surname><given-names>S</given-names></name><name><surname>Aryal</surname><given-names>P</given-names></name><name><surname>Kunhapan</surname><given-names>B</given-names></name><name><surname>Katanyoo</surname><given-names>W</given-names></name><name><surname>Chuenkongkaew</surname><given-names>W</given-names></name><name><surname>Lertrit</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of the variants in PARL, the nuclear modifier gene, responsible for the expression of LHON patients in Thailand</article-title><source>Experimental Eye Research</source><volume>116</volume><fpage>55</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2013.08.007</pub-id><pub-id pub-id-type="pmid">23973714</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Analysis of mitochondrial respiratory chain supercomplexes using blue native polyacrylamide gel electrophoresis (BN-PAGE)</article-title><source>Current Protocols in Mouse Biology</source><volume>6</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/9780470942390.mo150182</pub-id><pub-id pub-id-type="pmid">26928661</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>MH</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Tuo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zang</surname><given-names>ZJ</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Lahn</surname><given-names>BT</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction</article-title><source>Cell Research</source><volume>24</volume><fpage>1466</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.149</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Kon</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>S-J</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Baer</surname><given-names>R</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ferroptosis as a p53-mediated activity during tumour suppression</article-title><source>Nature</source><volume>520</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/nature14344</pub-id><pub-id pub-id-type="pmid">25799988</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>SM</given-names></name><name><surname>Lazarou</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Kane</surname><given-names>LA</given-names></name><name><surname>Narendra</surname><given-names>DP</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL</article-title><source>The Journal of Cell Biology</source><volume>191</volume><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1083/jcb.201008084</pub-id><pub-id pub-id-type="pmid">21115803</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Nikkanen</surname><given-names>J</given-names></name><name><surname>Yatsuga</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Pradhan</surname><given-names>S</given-names></name><name><surname>Kivelä</surname><given-names>R</given-names></name><name><surname>Pessia</surname><given-names>A</given-names></name><name><surname>Velagapudi</surname><given-names>V</given-names></name><name><surname>Suomalainen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.07.007</pub-id><pub-id pub-id-type="pmid">28768179</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis</article-title><source>Cell and Tissue Research</source><volume>330</volume><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1007/s00441-007-0474-7</pub-id><pub-id pub-id-type="pmid">17874251</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>VAN</given-names></name><name><surname>Bezjian</surname><given-names>CT</given-names></name><name><surname>Pfeiffer</surname><given-names>S</given-names></name><name><surname>Ringelstetter</surname><given-names>L</given-names></name><name><surname>Müller</surname><given-names>C</given-names></name><name><surname>Zandkarimi</surname><given-names>F</given-names></name><name><surname>Merl-Pham</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>X</given-names></name><name><surname>Anastasov</surname><given-names>N</given-names></name><name><surname>Kössl</surname><given-names>J</given-names></name><name><surname>Brandner</surname><given-names>S</given-names></name><name><surname>Daniels</surname><given-names>JD</given-names></name><name><surname>Schmitt-Kopplin</surname><given-names>P</given-names></name><name><surname>Hauck</surname><given-names>SM</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name><name><surname>Hadian</surname><given-names>K</given-names></name><name><surname>Schick</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling</article-title><source>ACS Central Science</source><volume>6</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.9b01063</pub-id><pub-id pub-id-type="pmid">31989025</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühl</surname><given-names>I</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Atanassov</surname><given-names>I</given-names></name><name><surname>Kuznetsova</surname><given-names>I</given-names></name><name><surname>Hinze</surname><given-names>Y</given-names></name><name><surname>Mourier</surname><given-names>A</given-names></name><name><surname>Filipovska</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals</article-title><source>eLife</source><volume>6</volume><elocation-id>e30952</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30952</pub-id><pub-id pub-id-type="pmid">29132502</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leichtmann-Bardoogo</surname><given-names>Y</given-names></name><name><surname>Cohen</surname><given-names>LA</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Marohn</surname><given-names>B</given-names></name><name><surname>Schubert</surname><given-names>S</given-names></name><name><surname>Meinhardt</surname><given-names>A</given-names></name><name><surname>Meyron-Holtz</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Compartmentalization and regulation of iron metabolism proteins protect male germ cells from iron overload</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>302</volume><fpage>E1519</fpage><lpage>E1530</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00007.2012</pub-id><pub-id pub-id-type="pmid">22496346</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y-S</given-names></name><name><surname>Liu</surname><given-names>C-Y</given-names></name><name><surname>Chen</surname><given-names>P-W</given-names></name><name><surname>Wang</surname><given-names>C-Y</given-names></name><name><surname>Chen</surname><given-names>H-C</given-names></name><name><surname>Tsao</surname><given-names>C-W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Coenzyme Q<sub>10</sub> amends testicular function and spermatogenesis in male mice exposed to cigarette smoke by modulating oxidative stress and inflammation</article-title><source>American Journal of Translational Research</source><volume>13</volume><fpage>10142</fpage><lpage>10154</lpage><pub-id pub-id-type="pmid">34650686</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>p53 in ferroptosis regulation: the new weapon for the old guardian</article-title><source>Cell Death &amp; Differentiation</source><volume>29</volume><fpage>895</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-00943-y</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Poirier</surname><given-names>C</given-names></name><name><surname>Gaspar</surname><given-names>T</given-names></name><name><surname>Gratzke</surname><given-names>C</given-names></name><name><surname>Harrison</surname><given-names>W</given-names></name><name><surname>Busija</surname><given-names>D</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Andersson</surname><given-names>K-E</given-names></name><name><surname>Overbeek</surname><given-names>PA</given-names></name><name><surname>Bishop</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice</article-title><source>Biology of Reproduction</source><volume>78</volume><fpage>601</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.107.065987</pub-id><pub-id pub-id-type="pmid">18094351</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Karuppagounder</surname><given-names>SS</given-names></name><name><surname>Springer</surname><given-names>DA</given-names></name><name><surname>Allen</surname><given-names>MD</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Chao</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Lenardo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4930</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5930</pub-id><pub-id pub-id-type="pmid">25222142</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luna-Sánchez</surname><given-names>M</given-names></name><name><surname>Hidalgo-Gutiérrez</surname><given-names>A</given-names></name><name><surname>Hildebrandt</surname><given-names>TM</given-names></name><name><surname>Chaves-Serrano</surname><given-names>J</given-names></name><name><surname>Barriocanal-Casado</surname><given-names>E</given-names></name><name><surname>Santos-Fandila</surname><given-names>Á</given-names></name><name><surname>Romero</surname><given-names>M</given-names></name><name><surname>Sayed</surname><given-names>RK</given-names></name><name><surname>Duarte</surname><given-names>J</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Schuelke</surname><given-names>M</given-names></name><name><surname>Distelmaier</surname><given-names>F</given-names></name><name><surname>Escames</surname><given-names>G</given-names></name><name><surname>Acuña-Castroviejo</surname><given-names>D</given-names></name><name><surname>López</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome</article-title><source>EMBO Molecular Medicine</source><volume>9</volume><fpage>78</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.15252/emmm.201606345</pub-id><pub-id pub-id-type="pmid">27856619</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiorino</surname><given-names>M</given-names></name><name><surname>Scapin</surname><given-names>M</given-names></name><name><surname>Ursini</surname><given-names>F</given-names></name><name><surname>Biasolo</surname><given-names>M</given-names></name><name><surname>Bosello</surname><given-names>V</given-names></name><name><surname>Flohé</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Distinct promoters determine alternative transcription of gpx-4 into phospholipid-hydroperoxide glutathione peroxidase variants</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>34286</fpage><lpage>34290</lpage><pub-id pub-id-type="doi">10.1074/jbc.M305327200</pub-id><pub-id pub-id-type="pmid">12819198</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname><given-names>A</given-names></name><name><surname>Balercia</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Coenzyme Q(10) in male infertility: physiopathology and therapy</article-title><source>BioFactors</source><volume>37</volume><fpage>374</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1002/biof.164</pub-id><pub-id pub-id-type="pmid">21989906</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lei</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Koppula</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Zhuang</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>B</given-names></name><name><surname>Poyurovsky</surname><given-names>MV</given-names></name><name><surname>Olszewski</surname><given-names>K</given-names></name><name><surname>Gan</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer</article-title><source>Nature</source><volume>593</volume><fpage>586</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03539-7</pub-id><pub-id pub-id-type="pmid">33981038</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martikainen</surname><given-names>MH</given-names></name><name><surname>Grady</surname><given-names>JP</given-names></name><name><surname>Ng</surname><given-names>YS</given-names></name><name><surname>Alston</surname><given-names>CL</given-names></name><name><surname>Gorman</surname><given-names>GS</given-names></name><name><surname>Taylor</surname><given-names>RW</given-names></name><name><surname>McFarland</surname><given-names>R</given-names></name><name><surname>Turnbull</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Decreased male reproductive success in association with mitochondrial dysfunction</article-title><source>European Journal of Human Genetics</source><volume>25</volume><fpage>1162</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2017.114</pub-id><pub-id pub-id-type="pmid">28812649</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>MR</given-names></name><name><surname>Silva</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ultrastructure of spermatogonia and primary spermatocytes of C57BL6J mice</article-title><source>Anatomia, Histologia, Embryologia</source><volume>30</volume><fpage>129</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">11447934</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuibban</surname><given-names>GA</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Juusola</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Normal mitochondrial dynamics requires rhomboid-7 and affects <italic>Drosophila</italic> lifespan and neuronal function</article-title><source>Current Biology</source><volume>16</volume><fpage>982</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.03.062</pub-id><pub-id pub-id-type="pmid">16713954</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meistrich</surname><given-names>ML</given-names></name><name><surname>Hess</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Assessment of spermatogenesis through staging of seminiferous tubules</article-title><source>Methods Mol Biolactions</source><volume>927</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-038-0</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moosmann</surname><given-names>B</given-names></name><name><surname>Behl</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway</article-title><source>Trends in Cardiovascular Medicine</source><volume>14</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2004.08.003</pub-id><pub-id pub-id-type="pmid">15542379</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakada</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>S-I</given-names></name><name><surname>Yonekawa</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>J-I</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondria-related male infertility</article-title><source>PNAS</source><volume>103</volume><fpage>15148</fpage><lpage>15153</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604641103</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oresti</surname><given-names>GM</given-names></name><name><surname>Reyes</surname><given-names>JG</given-names></name><name><surname>Luquez</surname><given-names>JM</given-names></name><name><surname>Osses</surname><given-names>N</given-names></name><name><surname>Furland</surname><given-names>NE</given-names></name><name><surname>Aveldaño</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differentiation-related changes in lipid classes with long-chain and very long-chain polyenoic fatty acids in rat spermatogenic cells</article-title><source>Journal of Lipid Research</source><volume>51</volume><fpage>2909</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1194/jlr.M006429</pub-id><pub-id pub-id-type="pmid">20610732</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>MA</given-names></name><name><surname>Magtanong</surname><given-names>L</given-names></name><name><surname>Dixon</surname><given-names>SJ</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dietary Lipids Induce Ferroptosis in <italic>Caenorhabditis elegans</italic> and Human Cancer Cells</article-title><source>Developmental Cell</source><volume>54</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.06.019</pub-id><pub-id pub-id-type="pmid">32652074</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Pérez</surname><given-names>R</given-names></name><name><surname>Lobo-Jarne</surname><given-names>T</given-names></name><name><surname>Milenkovic</surname><given-names>D</given-names></name><name><surname>Mourier</surname><given-names>A</given-names></name><name><surname>Bratic</surname><given-names>A</given-names></name><name><surname>García-Bartolomé</surname><given-names>A</given-names></name><name><surname>Fernández-Vizarra</surname><given-names>E</given-names></name><name><surname>Cadenas</surname><given-names>S</given-names></name><name><surname>Delmiro</surname><given-names>A</given-names></name><name><surname>García-Consuegra</surname><given-names>I</given-names></name><name><surname>Arenas</surname><given-names>J</given-names></name><name><surname>Martín</surname><given-names>MA</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name><name><surname>Ugalde</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>COX7A2L Is a Mitochondrial Complex III Binding Protein that Stabilizes the III2+IV Supercomplex without Affecting Respirasome Formation</article-title><source>Cell Reports</source><volume>16</volume><fpage>2387</fpage><lpage>2398</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.07.081</pub-id><pub-id pub-id-type="pmid">27545886</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesta</surname><given-names>D</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle</article-title><source>Methods in Molecular Biology</source><volume>810</volume><fpage>25</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-382-0_3</pub-id><pub-id pub-id-type="pmid">22057559</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajender</surname><given-names>S</given-names></name><name><surname>Rahul</surname><given-names>P</given-names></name><name><surname>Mahdi</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitochondria, spermatogenesis and male infertility</article-title><source>Mitochondrion</source><volume>10</volume><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2010.05.015</pub-id><pub-id pub-id-type="pmid">20595008</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Aguilera</surname><given-names>J</given-names></name><name><surname>Cortés</surname><given-names>A</given-names></name><name><surname>Fernández-Ayala</surname><given-names>D</given-names></name><name><surname>Navas</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biochemical Assessment of Coenzyme Q10 Deficiency</article-title><source>Journal of Clinical Medicine</source><volume>6</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.3390/jcm6030027</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saita</surname><given-names>S</given-names></name><name><surname>Nolte</surname><given-names>H</given-names></name><name><surname>Fiedler</surname><given-names>KU</given-names></name><name><surname>Kashkar</surname><given-names>H</given-names></name><name><surname>Venne</surname><given-names>AS</given-names></name><name><surname>Zahedi</surname><given-names>RP</given-names></name><name><surname>Krüger</surname><given-names>M</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>318</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/ncb3488</pub-id><pub-id pub-id-type="pmid">28288130</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved!</article-title><source>Cell Metabolism</source><volume>31</volume><fpage>13</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.12.007</pub-id><pub-id pub-id-type="pmid">31951565</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>AB</given-names></name><name><surname>Dobson</surname><given-names>ETA</given-names></name><name><surname>Rueden</surname><given-names>CT</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Jug</surname><given-names>F</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ImageJ ecosystem: Open-source software for image visualization, processing, and analysis</article-title><source>Protein Science</source><volume>30</volume><fpage>234</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1002/pro.3993</pub-id><pub-id pub-id-type="pmid">33166005</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibt</surname><given-names>TM</given-names></name><name><surname>Proneth</surname><given-names>B</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Role of GPX4 in ferroptosis and its pharmacological implication</article-title><source>Free Radical Biology &amp; Medicine</source><volume>133</volume><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.09.014</pub-id><pub-id pub-id-type="pmid">30219704</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Förster</surname><given-names>H</given-names></name><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Wirth</surname><given-names>EK</given-names></name><name><surname>Culmsee</surname><given-names>C</given-names></name><name><surname>Plesnila</surname><given-names>N</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Rådmark</surname><given-names>O</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Bornkamm</surname><given-names>GW</given-names></name><name><surname>Schweizer</surname><given-names>U</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death</article-title><source>Cell Metabolism</source><volume>8</volume><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.07.005</pub-id><pub-id pub-id-type="pmid">18762024</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>S</given-names></name><name><surname>Kanamaru</surname><given-names>Y</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Nishihara</surname><given-names>A</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>H</given-names></name><name><surname>Kamiyama</surname><given-names>M</given-names></name><name><surname>Maruyama</surname><given-names>J</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name><name><surname>Ishihara</surname><given-names>N</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Ichijo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>34635</fpage><lpage>34645</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.357509</pub-id><pub-id pub-id-type="pmid">22915595</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Grimes</surname><given-names>DA</given-names></name><name><surname>Racacho</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ross</surname><given-names>OA</given-names></name><name><surname>Farrer</surname><given-names>M</given-names></name><name><surname>McQuibban</surname><given-names>GA</given-names></name><name><surname>Bulman</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson’s disease</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>1966</fpage><lpage>1974</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr077</pub-id><pub-id pub-id-type="pmid">21355049</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Skouta</surname><given-names>R</given-names></name><name><surname>Kaplan</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>WS</given-names></name><name><surname>Hayano</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>SJ</given-names></name><name><surname>Brown</surname><given-names>LM</given-names></name><name><surname>Valenzuela</surname><given-names>CA</given-names></name><name><surname>Wolpaw</surname><given-names>AJ</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis</article-title><source>Nature Chemical Biology</source><volume>12</volume><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2079</pub-id><pub-id pub-id-type="pmid">27159577</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>NR</given-names></name><name><surname>Anderson</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Isolation of mitochondria from rat brain using Percoll density gradient centrifugation</article-title><source>Nature Protocols</source><volume>3</volume><fpage>1228</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.105</pub-id><pub-id pub-id-type="pmid">18600228</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinazzi</surname><given-names>M</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PARL: The mitochondrial rhomboid protease</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>60</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2016.07.034</pub-id><pub-id pub-id-type="pmid">27502471</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinazzi</surname><given-names>M</given-names></name><name><surname>Radaelli</surname><given-names>E</given-names></name><name><surname>Horré</surname><given-names>K</given-names></name><name><surname>Arranz</surname><given-names>AM</given-names></name><name><surname>Gounko</surname><given-names>NV</given-names></name><name><surname>Agostinis</surname><given-names>P</given-names></name><name><surname>Maia</surname><given-names>TM</given-names></name><name><surname>Impens</surname><given-names>F</given-names></name><name><surname>Morais</surname><given-names>VA</given-names></name><name><surname>Lopez-Lluch</surname><given-names>G</given-names></name><name><surname>Serneels</surname><given-names>L</given-names></name><name><surname>Navas</surname><given-names>P</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PARL deficiency in mouse causes Complex III defects, coenzyme Q depletion, and Leigh-like syndrome</article-title><source>PNAS</source><volume>116</volume><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1073/pnas.1811938116</pub-id><pub-id pub-id-type="pmid">30578322</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefely</surname><given-names>JA</given-names></name><name><surname>Pagliarini</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biochemistry of mitochondrial coenzyme q biosynthesis</article-title><source>Trends in Biochemical Sciences</source><volume>42</volume><fpage>824</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2017.06.008</pub-id><pub-id pub-id-type="pmid">28927698</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwell</surname><given-names>BR</given-names></name><name><surname>Friedmann Angeli</surname><given-names>JP</given-names></name><name><surname>Bayir</surname><given-names>H</given-names></name><name><surname>Bush</surname><given-names>AI</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>SJ</given-names></name><name><surname>Fulda</surname><given-names>S</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Hatzios</surname><given-names>SK</given-names></name><name><surname>Kagan</surname><given-names>VE</given-names></name><name><surname>Noel</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Linkermann</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>ME</given-names></name><name><surname>Overholtzer</surname><given-names>M</given-names></name><name><surname>Oyagi</surname><given-names>A</given-names></name><name><surname>Pagnussat</surname><given-names>GC</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Ran</surname><given-names>Q</given-names></name><name><surname>Rosenfeld</surname><given-names>CS</given-names></name><name><surname>Salnikow</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Torti</surname><given-names>FM</given-names></name><name><surname>Torti</surname><given-names>SV</given-names></name><name><surname>Toyokuni</surname><given-names>S</given-names></name><name><surname>Woerpel</surname><given-names>KA</given-names></name><name><surname>Zhang</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</article-title><source>Cell</source><volume>171</volume><fpage>273</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.021</pub-id><pub-id pub-id-type="pmid">28985560</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwell</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications</article-title><source>Cell</source><volume>185</volume><fpage>2401</fpage><lpage>2421</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.06.003</pub-id><pub-id pub-id-type="pmid">35803244</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suomalainen</surname><given-names>A</given-names></name><name><surname>Battersby</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial diseases: the contribution of organelle stress responses to pathology</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>19</volume><fpage>77</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.66</pub-id><pub-id pub-id-type="pmid">28792006</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanisms of modulation of ferroptosis and its role in central nervous system diseases</article-title><source>Frontiers in Pharmacology</source><volume>12</volume><elocation-id>657033</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2021.657033</pub-id><pub-id pub-id-type="pmid">34149412</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarrant</surname><given-names>JC</given-names></name><name><surname>Binder</surname><given-names>ZA</given-names></name><name><surname>Bugatti</surname><given-names>M</given-names></name><name><surname>Vermi</surname><given-names>W</given-names></name><name><surname>van den Oord</surname><given-names>J</given-names></name><name><surname>Ranieri</surname><given-names>B</given-names></name><name><surname>Assenmacher</surname><given-names>C-A</given-names></name><name><surname>Hoepp</surname><given-names>N</given-names></name><name><surname>O’Rourke</surname><given-names>DM</given-names></name><name><surname>Shan</surname><given-names>X</given-names></name><name><surname>Danet-Desnoyers</surname><given-names>G</given-names></name><name><surname>Radaelli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pathology of macrophage activation syndrome in humanized NSGS mice</article-title><source>Research in Veterinary Science</source><volume>134</volume><fpage>137</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2020.12.003</pub-id><pub-id pub-id-type="pmid">33383491</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>T-L</given-names></name><name><surname>Cuadros</surname><given-names>AM</given-names></name><name><surname>Shah</surname><given-names>H</given-names></name><name><surname>Hung</surname><given-names>WHW</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Rubin</surname><given-names>DHF</given-names></name><name><surname>Boe</surname><given-names>RH</given-names></name><name><surname>Rath</surname><given-names>S</given-names></name><name><surname>Eaton</surname><given-names>JK</given-names></name><name><surname>Piccioni</surname><given-names>F</given-names></name><name><surname>Goodale</surname><given-names>A</given-names></name><name><surname>Kalani</surname><given-names>Z</given-names></name><name><surname>Doench</surname><given-names>JG</given-names></name><name><surname>Root</surname><given-names>DE</given-names></name><name><surname>Schreiber</surname><given-names>SL</given-names></name><name><surname>Vafai</surname><given-names>SB</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A compendium of genetic modifiers of mitochondrial dysfunction reveals intra-organelle buffering</article-title><source>Cell</source><volume>179</volume><fpage>1222</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.032</pub-id><pub-id pub-id-type="pmid">31730859</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trifunovic</surname><given-names>A</given-names></name><name><surname>Wredenberg</surname><given-names>A</given-names></name><name><surname>Falkenberg</surname><given-names>M</given-names></name><name><surname>Spelbrink</surname><given-names>JN</given-names></name><name><surname>Rovio</surname><given-names>AT</given-names></name><name><surname>Bruder</surname><given-names>CE</given-names></name><name><surname>Bohlooly-Y</surname><given-names>M</given-names></name><name><surname>Gidlöf</surname><given-names>S</given-names></name><name><surname>Oldfors</surname><given-names>A</given-names></name><name><surname>Wibom</surname><given-names>R</given-names></name><name><surname>Törnell</surname><given-names>J</given-names></name><name><surname>Jacobs</surname><given-names>HT</given-names></name><name><surname>Larsson</surname><given-names>N-G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Premature ageing in mice expressing defective mitochondrial DNA polymerase</article-title><source>Nature</source><volume>429</volume><fpage>417</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/nature02517</pub-id><pub-id pub-id-type="pmid">15164064</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>EM</given-names></name><name><surname>Abou-Sleiman</surname><given-names>PM</given-names></name><name><surname>Caputo</surname><given-names>V</given-names></name><name><surname>Muqit</surname><given-names>MMK</given-names></name><name><surname>Harvey</surname><given-names>K</given-names></name><name><surname>Gispert</surname><given-names>S</given-names></name><name><surname>Ali</surname><given-names>Z</given-names></name><name><surname>Del Turco</surname><given-names>D</given-names></name><name><surname>Bentivoglio</surname><given-names>AR</given-names></name><name><surname>Healy</surname><given-names>DG</given-names></name><name><surname>Albanese</surname><given-names>A</given-names></name><name><surname>Nussbaum</surname><given-names>R</given-names></name><name><surname>González-Maldonado</surname><given-names>R</given-names></name><name><surname>Deller</surname><given-names>T</given-names></name><name><surname>Salvi</surname><given-names>S</given-names></name><name><surname>Cortelli</surname><given-names>P</given-names></name><name><surname>Gilks</surname><given-names>WP</given-names></name><name><surname>Latchman</surname><given-names>DS</given-names></name><name><surname>Harvey</surname><given-names>RJ</given-names></name><name><surname>Dallapiccola</surname><given-names>B</given-names></name><name><surname>Auburger</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Hereditary early-onset Parkinson’s disease caused by mutations in PINK1</article-title><source>Science</source><volume>304</volume><fpage>1158</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1126/science.1096284</pub-id><pub-id pub-id-type="pmid">15087508</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varuzhanyan</surname><given-names>G</given-names></name><name><surname>Rojansky</surname><given-names>R</given-names></name><name><surname>Sweredoski</surname><given-names>MJ</given-names></name><name><surname>Graham</surname><given-names>RLJ</given-names></name><name><surname>Hess</surname><given-names>S</given-names></name><name><surname>Ladinsky</surname><given-names>MS</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitochondrial fusion is required for spermatogonial differentiation and meiosis</article-title><source>eLife</source><volume>8</volume><elocation-id>e51601</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51601</pub-id><pub-id pub-id-type="pmid">31596236</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varuzhanyan</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial dynamics during spermatogenesis</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs235937</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.235937</pub-id><pub-id pub-id-type="pmid">32675215</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varuzhanyan</surname><given-names>G</given-names></name><name><surname>Ladinsky</surname><given-names>MS</given-names></name><name><surname>Yamashita</surname><given-names>S-I</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Kanki</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fis1 ablation in the male germline disrupts mitochondrial morphology and mitophagy, and arrests spermatid maturation</article-title><source>Development</source><volume>148</volume><elocation-id>dev199686</elocation-id><pub-id pub-id-type="doi">10.1242/dev.199686</pub-id><pub-id pub-id-type="pmid">34355730</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The complexity of making ubiquinone</article-title><source>Trends in Endocrinology and Metabolism</source><volume>30</volume><fpage>929</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2019.08.009</pub-id><pub-id pub-id-type="pmid">31601461</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mitochondrial regulation during male germ cell development</article-title><source>Cellular and Molecular Life Sciences</source><volume>79</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.1007/s00018-022-04134-3</pub-id><pub-id pub-id-type="pmid">35072818</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wortmann</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Pircher</surname><given-names>J</given-names></name><name><surname>Hellfritsch</surname><given-names>J</given-names></name><name><surname>Aichler</surname><given-names>M</given-names></name><name><surname>Vegi</surname><given-names>N</given-names></name><name><surname>Kölle</surname><given-names>P</given-names></name><name><surname>Kuhlencordt</surname><given-names>P</given-names></name><name><surname>Walch</surname><given-names>A</given-names></name><name><surname>Pohl</surname><given-names>U</given-names></name><name><surname>Bornkamm</surname><given-names>GW</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name><name><surname>Beck</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice</article-title><source>Circulation Research</source><volume>113</volume><fpage>408</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.279984</pub-id><pub-id pub-id-type="pmid">23770613</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Geng</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Shan</surname><given-names>B</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Chaperone-mediated autophagy is involved in the execution of ferroptosis</article-title><source>PNAS</source><volume>116</volume><fpage>2996</fpage><lpage>3005</lpage><pub-id pub-id-type="doi">10.1073/pnas.1819728116</pub-id><pub-id pub-id-type="pmid">30718432</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Abou-Hamdan</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Désaubry</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis</article-title><source>Autophagy</source><volume>16</volume><fpage>419</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1080/15548627.2019.1628520</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The mammalian synaptonemal complex: a scaffold and beyond</article-title><source>Genome Dynamics</source><volume>5</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1159/000166620</pub-id><pub-id pub-id-type="pmid">18948708</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yant</surname><given-names>LJ</given-names></name><name><surname>Ran</surname><given-names>Q</given-names></name><name><surname>Rao</surname><given-names>L</given-names></name><name><surname>Van Remmen</surname><given-names>H</given-names></name><name><surname>Shibatani</surname><given-names>T</given-names></name><name><surname>Belter</surname><given-names>JG</given-names></name><name><surname>Motta</surname><given-names>L</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Prolla</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults</article-title><source>Free Radical Biology &amp; Medicine</source><volume>34</volume><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/s0891-5849(02)01360-6</pub-id><pub-id pub-id-type="pmid">12566075</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The metabolic underpinnings of ferroptosis</article-title><source>Cell Metabolism</source><volume>32</volume><fpage>920</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.10.011</pub-id><pub-id pub-id-type="pmid">33217331</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84710.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Wei</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.11.22.517461" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.22.517461"/></front-stub><body><p>This manuscript reports an important finding that spermatogenic defects in Parl KO mice, a genetic model for Leigh syndrome, may result from mitochondrial defects leading to ferroptosis. The finding is of significance because male germ cell ferroptosis has not been well characterized before. The data as a whole strongly support ferroptosis as a mechanism for germ cell death in the Parl KO. However, potential non-ferroptosis and 'accidental' necrosis cannot be excluded, and the potential effects of quantitative immunofluorescent staining, instead of assays using purified spermatogenic cells, on the conclusion drawn should be considered.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84710.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.22.517461">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.11.22.517461v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Mitochondrial defects leading to arrested spermatogenesis and ferroptosis in a mouse model of Leigh Syndrome&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ricardo Azziz as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Definitive evidence for germ cell ferroptosis.</p><p>2) Quantitative analyses using purified spermatogenic cells instead of total testes as the cellular compositions are different between KOs and controls.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. In Figure 1A, it would be more useful to show testis/body weight ratio instead of the two metrics separately.</p><p>2. In Figure 1, SYCP-1 is used in the associated text but SCP-1 is used in the figure/legend; only one name should be used to avoid confusion.</p><p>3. Line 176 typo: &quot;detail&quot; -&gt; &quot;detailed&quot;.</p><p>4. Figure 2 – supplement 2 (activated caspase staining) is only referenced in association with Figure 6. It seems more appropriate to move this panel to the Figure 6 supplement.</p><p>5. For Figure 4B, the method for quantitating mtDNA is not specified in either the text or legend. It is provided in the methods (qPCR) but should also be specified in the main manuscript.</p><p>6. The various factors and pathways discussed tested throughout the study are complex. It would be helpful to have a cartoon or model figure outlining the proposed pathway and the differences between WT and Parl-/-.</p><p>7. Several details are missing in the figure legends; making the figures difficult to interpret:</p><p>a. In the legend to Figure 3A, the protein used as a loading control is not specified.</p><p>b. In Figure 4C, it is difficult to know which bands indicate assembly defects compared to normal complex assembly.</p><p>c. In Figure 4E, the abbreviation RCR is not explained in either the text or legend.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. Ferroptosis is not reported in mammalian germ cells. However, the data presented here only indirectly support the possibility of germ cell ferroptosis in the mutants. The authors should clarify the definitions of ferroptosis in the field and demonstrate definitive evidence of germ-cell ferroptosis in mammals. P53 is not the only marker for ferroptosis. The HNE data is interesting but does not prove the main point.</p><p>2. Figure 2—figure supplement 2 shows &quot;Absence of apoptosis in degenerated Parl-/- testis.&quot; However, apoptosis needs to be quantitatively evaluated in the mutants. Apoptosis is usually not so frequent in other mutants showing meiotic defects. Also, wild-type mice usually show a low rate of apoptosis. This data is not sufficient to demonstrate the &quot;Absence of apoptosis.&quot;</p><p>3. The authors have done many analyses using the whole-testis (such as western or others; Figure 3A, 4A, 4B, 4C, 4D, 4E, 5B, 6A, 6B, 6 sup 1A-C, 6 sup 2A). However, the mutant testes were depleted with late germ cells, and the composition of germ cells was apparently different between the wild-type and mutant testes. The authors should confirm these results using analyses of juvenile testes (in which cellular composition is not changed yet) or isolated germ cells of specific stages from wild-type and mutant testes.</p><p>4. Results of fertility tests should be provided.</p><p>5. Figure 1—figure supplement 1: PARL deficiency should be confirmed in mutant Leydig cells. Otherwise, there is no evidence that PARL is depleted in the conditional mutants, as suggested.</p><p>6. Line 121-124: chromosome synapsis was not examined in the mutant. In this context, Line 242-244 explains the chromatin defects in the mutants, but there is no clear characterization.</p><p>7. Figure 2—figure supplement 2 should be described in the order of the explanation.</p><p>8. Line 155-158: The Pink1 single mutants should be characterized before examining the double mutants. In flies, PINK1 is required for spermatogenesis (Clark et al., Nature 2006: PMID 16672981). Thus, it is interesting if PINK1 is not required for spermatogenesis in mice. Results of fertility tests should be provided here as well.</p><p>9. Figure 4D is not possible to interpret. Please show the wild-type and mutant data separately and explain in a way general audiences can understand.</p><p>10. The Discussion section is disorganized and hard to read.</p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for resubmitting your work entitled &quot;Mitochondrial defects leading to arrested spermatogenesis and ferroptosis in the PARL deficient mouse model of Leigh Syndrome&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Diane Harper (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>1) Add a paragraph summarizing the definitions of ferroptosis in mammals and explain how observation here fulfills these criteria.</p><p>2) The cellular compositions are different in KO vs control testes. Specifically, the mutant testes are enriched in spermatogonia, while the controls are enriched in spermatids. Therefore, purification of specific spermatogenic cell types followed by molecular assays is necessary.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors have addressed my primary concerns by providing quantitation of immunofluorescence microscopy and EM images, as well as additional controls and explanations. Functional infertility assessed by co-housing of mutant males with wild type females, which is an important addition to the report of azoospermia in describing an infertility phenotype, is now described at the beginning of the Results section. The paper makes a strong case for ferroptosis as a mechanism for germ cell death in Parl mutants and represents an advance in the fields of male fertility and mitochondrial function. There are two remaining points that I think should be acknowledged in the Discussion section:</p><p>1) I agree with reviewer 2 that analysis of stage-specific germ cells is important for the conclusions. In their rebuttal, the authors argue that deletion of Parl in all cells in the germline (whole body) knockout makes this concern irrelevant; this is not true because Parl is likely functioning differently across different germ cell types, making differing cell compositions a potential artifact in bulk assays. In addition, in a whole-body knockout there may be cell non-autonomous effects from testis somatic cells. The data from 4-week testes referred to in the rebuttal will not address the cell composition issue because by 4 weeks (28 days) there will be advanced round spermatids in control testes, meaning that cell compositions will differ between KO and control.</p><p>Taking all the data together, I think that the immunofluorescence data strongly supports a cell autonomous effect of Parl knockout in spermatocytes as the authors suggest. However, I think that they should acknowledge the possible issues related to mixed cell populations and somatic cell effects in the Discussion section.</p><p>2) Similarly, the data as a whole strongly supports ferroptosis as a mechanism for germ cell death in the Parl KO, but it is difficult to fully exclude non-ferroptotic 'accidental' necrosis. This should also be acknowledged in the Discussion section.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>In this revision, I appreciate the authors' massive efforts to address my previous concerns, but I do not think my main concerns were not effectively addressed. The study provided several indirect evidence of germ cell ferroptosis, but I do not think the results firmly established the occurrence of germ cell ferroptosis. In general, perturbations in mitochondria dynamics could be expected to disrupt spermatogenesis. It would be necessary to clearly define germ-cell ferroptosis to explain the specific phenotype of the PARL mutants. Overall, I appreciate the potential impact; but I am not fully convinced by the main conclusion reported in this study yet.</p><p>1. The main issue is that the manuscript, including some of the revised parts, was not clearly written. I still do not understand many parts. Now, the abstract, results, and discussion are hard to read. The authors should clarify the contents and ask a professional editor to clarify the language. I am sorry that it took time to review the revised manuscript.</p><p>2. Ferroptosis is not reported in mammalian germ cells. However, the revised manuscript only indirectly supports the possibility of germ-cell ferroptosis in the mutants. The authors did not address my previous concern: the authors should clarify the definitions of ferroptosis in the field and demonstrate definitive evidence of germ-cell ferroptosis in mammals. Again, P53 is not the only marker for ferroptosis. Please add a paragraph summarizing the definitions of ferroptosis in mammals and explain how observation here fulfills these criteria.</p><p>3. The mutant testes were depleted with late germ cells, and the composition of germ cells was apparently different between the wild-type and mutant testes. The issues are that the mutant testes are enriched with spermatogonia, and the controls are enriched with the late stages of spermatogenesis. I appreciate the authors have done many analyses using the whole testis in this revision. However, they did not address this main point. I understand it can be challenging to isolate germ cells of specific stages from wild-type and mutant testes. At least, the authors should confirm the main conclusions using analyses of juvenile testes (in which cellular composition is not changed yet). For example, at least the reduction of CoQ (Figure 5A) should be examined to solidify the main conclusion.</p><p>4. I suggested that &quot;results of fertility tests should be provided.&quot;At least, please show how many mice were examined for what duration.</p><p>5. Figure 1—figure supplement 1: PARL deficiency should be confirmed in mutant Leydig cells. In this case, I understand that there is no PARL antibody to confirm. This caveat can be noted.</p><p>6. Figure 4D is still not possible to interpret. Please clearly explain what this means in detail. Also, I found a weird mark in the middle of the panel.</p><p>7. New Figure 6C: GPX4 expression appears to be reduced in various cells in Parl-/- testes, but I do not see any cell-type specific reduction in spermatocytes. Is GPX4 highly expressed in other stages in the mutants?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84710.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Reviewer #1 (Recommendations for the authors):</p><p>1. In Figure 1A, it would be more useful to show testis/body weight ratio instead of the two metrics separately.</p></disp-quote><p>We included as suggested the testis/body weight ratio but kept also the information about testis and weight separately to avoid loss of information (the ratio alone for instance could decrease if the KO body weight increased).</p><disp-quote content-type="editor-comment"><p>2. In Figure 1, SYCP-1 is used in the associated text but SCP-1 is used in the figure/legend; only one name should be used to avoid confusion.</p></disp-quote><p>We modify the text as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>3. Line 176 typo: &quot;detail&quot; -&gt; &quot;detailed&quot;.</p></disp-quote><p>We modify the text as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>4. Figure 2 – supplement 2 (activated caspase staining) is only referenced in association with Figure 6. It seems more appropriate to move this panel to the Figure 6 supplement.</p></disp-quote><p>We agree and moved this figure to Figure 6—figure supplement 1 as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>5. For Figure 4B, the method for quantitating mtDNA is not specified in either the text or legend. It is provided in the methods (qPCR) but should also be specified in the main manuscript.</p></disp-quote><p>We modify the text as suggested by the reviewer adding this point in the legend. The method is detailed in the methods section.</p><disp-quote content-type="editor-comment"><p>6. The various factors and pathways discussed tested throughout the study are complex. It would be helpful to have a cartoon or model figure outlining the proposed pathway and the differences between WT and Parl-/-.</p></disp-quote><p>We agree with the reviewer. We added this cartoon in Figure 7 as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>7. Several details are missing in the figure legends; making the figures difficult to interpret:</p><p>a. In the legend to Figure 3A, the protein used as a loading control is not specified.</p></disp-quote><p>We specified that HSP60 is the loading control.</p><disp-quote content-type="editor-comment"><p>b. In Figure 4C, it is difficult to know which bands indicate assembly defects compared to normal complex assembly.</p></disp-quote><p>We modify the figure to highlight the identification of the different complexes as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>c. In Figure 4E, the abbreviation RCR is not explained in either the text or legend.</p></disp-quote><p>As suggested by the reviewer, we specify in the legend the abbreviation RCR being respiratory control ratio, which is a useful parameter to assess the efficiency of oxidative phosphorylation.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. Ferroptosis is not reported in mammalian germ cells. However, the data presented here only indirectly support the possibility of germ cell ferroptosis in the mutants. The authors should clarify the definitions of ferroptosis in the field and demonstrate definitive evidence of germ-cell ferroptosis in mammals. P53 is not the only marker for ferroptosis. The HNE data is interesting but does not prove the main point.</p></disp-quote><p>GPX4 is the major suppressors of ferroptosis, and the ablation of this protein alone induces ferroptosis. The virtual absence of GPX4 expression specifically found in <italic>Parl<sup>-/-</sup></italic> spermatocytes provides in our opinion robust evidence for ferroptosis in our model, since genetic or chemical inactivation of this enzyme alone is sufficient to induce ferroptosis in a variety of models. In addition, we discuss how Coenzyme Q, an established and independent suppressor of ferroptosis, is severely suppressed in <italic>Parl<sup>-/-</sup></italic> cells providing further evidence for this process.</p><p>Moreover, we provided quantitative analysis of 3 additional established biomarkers of ferroptosis in <italic>Parl<sup>-/-</sup></italic> spermatocytes, confirming highly significant pattern of expression consistent with ferroptosis: HNE (increase), Tfr1 (increase), p53 (increase). Altogether, we believe that our study provides definitive evidence of ferroptosis in spermatocytes. Finally, while this paper was under revision, an independent group led by Thomas Langer published a study on Nature Cell Biology finding increased susceptibility of ferroptosis of <italic>PARL-/-</italic> cells in culture treated with GPX4 inhibitors due to defective Coenzyme Q (Deshwal, S. et al. <italic>Nat Cell Biol</italic> 2023: doi:10.1038/s41556-022-01071-y). We believe that these works, one performed in vivo and the other in vitro, perfectly fit together strengthening both conclusions.</p><disp-quote content-type="editor-comment"><p>2. Figure 2—figure supplement 2 shows &quot;Absence of apoptosis in degenerated Parl-/- testis.&quot; However, apoptosis needs to be quantitatively evaluated in the mutants. Apoptosis is usually not so frequent in other mutants showing meiotic defects. Also, wild-type mice usually show a low rate of apoptosis. This data is not sufficient to demonstrate the &quot;Absence of apoptosis.&quot;</p></disp-quote><p>We provide now quantitative analysis of apoptosis in Figure 6—figure supplement 1. As suggested by the reviewer, few cells in both genotypes showed caspase 3 activation, so we corrected the sentence on “absence of apoptosis”, which is not accurate. We did not see a quantitative difference in the amount of caspase 3 + cells in the two genotypes. Most importantly, we did not see caspase 3 activation in the degenerating adluminal germ cells strongly indicating that apoptosis was not the main cell death mechanisms. Although we cannot rule out a very subtle participation of apoptosis in addition to ferroptosis in the reported phenotype, we believe we can safely conclude that apoptosis was not the main biological mechanism underlying the massive testis phenotype that we described.</p><disp-quote content-type="editor-comment"><p>3. The authors have done many analyses using the whole-testis (such as western or others; Figure 3A, 4A, 4B, 4C, 4D, 4E, 5B, 6A, 6B, 6 sup 1A-C, 6 sup 2A). However, the mutant testes were depleted with late germ cells, and the composition of germ cells was apparently different between the wild-type and mutant testes. The authors should confirm these results using analyses of juvenile testes (in which cellular composition is not changed yet) or isolated germ cells of specific stages from wild-type and mutant testes.</p></disp-quote><p>We agree with the reviewer that the cellular composition is different in KO vs WT and we added many morphometric and cell quantitative analysis in Figure 1—figure supplement 1 to better address this important point. Indeed, primary spermatocytes and to a lesser extent spermatogonia significantly accumulate in <italic>ParlKO</italic> vs WT due to the complete meiotic block, while there is a complete lack of post-meiotic spermatids. To address the reviewer concerns that changes in cellular composition might have affected our interpretation, we performed a series of cell-specific quantitative analysis in WT and mutant testes in order to eliminate any bias that may originate from differences in cell composition.</p><p>Figure 3A: since our study is on a germline KO for PARL, the effect of PARL deficiency on PARL substrates is the same in any cells, as previously reported in Spinazzi et al., 2019, so repeating the experiment on isolated germ cells would not provide any additional insight. Moreover, it is technically unfeasible to perform, being most of the PARL substrates undetectable by IHC due to absence of specific antibodies for this technique.</p><p>Figure 4A: as above, the mouse employed in the study is a germline KO for PARL, so PARL is absent in any cell, as previously described (Cipolat S et al. <italic>Cell.</italic> 2006), so repeating the experiment on isolated germ cells would not provide any useful insight. Moreover, there is no specific antibody currently available for PARL IHC.</p><p>Figure 4B<bold>:</bold> to address the question of whether mtDNA content may be different in WT vs <italic>Parl<sup>-/-</sup></italic> spermatocytes, we performed quantitative immunofluorescences experiments with antibodies stained for TFAM, a protein associated with mitochondrial nucleoids commonly used as biomarker for mtDNA abundance, and SCP-1, a marker of primary spermatocytes. We did not observe significant difference of TFAM expression in SCP-1+ cells as shown in the new Figure 4—figure supplement 1. These data rule out the possibility of significant decrease of mtDNA in <italic>Parl<sup>-/-</sup></italic> spermatocytes, that could explain the drastic mitochondrial respiratory chain defects that we describe.</p><p>Figure 4C: isolation of mitochondria, required for blue native gel electrophoresis requires a substantial amount of tissue/cells. This amount is impossible to reach after isolation of specific germ cells. We performed BNGE at an earlier stage (4 weeks), when the amount of tissue is sufficient for mitochondrial isolation, and the results are identical compared to those shown and Figure 4C. We can share this experiment if needed. Moreover, although it is not possible to precisely localize the severity of mitochondrial complex disassembly in different testis cells, we can safely affirm that the abnormalities shown in Figure 4C are definitely pathological since they do not respect the well characterized macromolecular organization of respiratory chain complexes and super complexes that is well known and conserved among different cell types even in different species.</p><p>Figure 4D<bold>:</bold> this graph, as explained in the text, is simply an illustrative example to describe to reader the protocol of high-resolution respirometry employed in the study.</p><p>Figure 4E: as for 4C, it is not realistic to perform mitochondrial isolation after germ cell isolation for the reasons above specified. Moreover, the procedure of germ cell isolation per se very likely would affect and compromise mitochondrial function and respiration. As explained in the text, to gain cell type-specific insights on mitochondrial function/electron transfer we performed hystoenzymatic assessment of cytochrome c oxydase (COX) activity, shown in Figure 4F. To further confirm our data we performed quantitative immunofluorescence analysis for COX4, a subunit of Complex IV of the respiratory chain, in SCP-1 positive primary spermatocytes, confirming a significant decrease in COX4 expression in primary spermatocytes of <italic>Parl-/-</italic> compared to WT. These results have been included in a new Figure 4—figure supplement 2.</p><p>Figure 5B: to address the reviewer concerns we performed quantitative immunofluorescence analysis for COQ4 in SCP-1 positive primary spermatocytes, confirming a significant decrease in COQ4 expression in primary spermatocytes of <italic>Parl-/-</italic> compared to WT. We added this new analysis in a new Figure 5—figure supplement 1.</p><p>Figure 6A: to address the reviewer concerns we performed quantitative immunofluorescence analysis for GPX4 in SCP-1 positive spermatocytes, confirming a dramatic decrease in GPX4 expression in primary spermatocytes of <italic>Parl-/-</italic> compared to WT (p=0.0013). We added this new analysis in a new Figure 6—figure supplement 2A. We also evaluated GPX4 expression in Sertoli cells with a similar approach and did not find significant differences (Figure 6—figure supplement 2A).</p><p>Figure 6B: to address the reviewer concerns we performed quantitative immunofluorescence analysis for HNE in SCP1 positive primary spermatocytes, confirming a dramatic increase in HNE expression in primary spermatocytes of <italic>Parl-/-</italic> compared to WT (p = 0.0002). We added this new analysis in Figure 6—figure supplement 5B.</p><p>Figure 6 sup1A, now Figure 6—figure supplement 3A: this experiment is not performed on whole-testis but on total mouse embryonic fibroblasts, as specified in the figure legend.</p><p>Figure 6 sup1B-C, now Figure 6—figure supplement 3B-C: 3B is not performed on whole-testis but on isolated mitochondria from different tissues (1B), and 3C on total brain tissue. These experiments show that the drastic effects on GPX4 and lipid peroxidation are not present in these tissues.</p><disp-quote content-type="editor-comment"><p>4. Results of fertility tests should be provided.</p></disp-quote><p>We specify in the text that the mice are totally infertile due to complete lack of sperm production.</p><disp-quote content-type="editor-comment"><p>5. Figure 1—figure supplement 1: PARL deficiency should be confirmed in mutant Leydig cells. Otherwise, there is no evidence that PARL is depleted in the conditional mutants, as suggested.</p></disp-quote><p>There is no currently available specific antibody for PARL immunohistochemistry, so it is not possible to directly quantify the effect of the Nestin-Cre deletion in Leydig cells at protein level. Nevertheless, the expression of Nestin in Leydig cells, that we and others before us verified, is expected to delete <italic>Parl</italic> by Cre recombinase, as in the nervous system. Moreover our extensive observations indicates that Leydig cells are structurally and functionally unaffected in the germline <italic>Parl-/-</italic> suggesting that Leydig cells are not major players of the drastic germ cell phenotype that we link to PARL deficiency.</p><disp-quote content-type="editor-comment"><p>6. Line 121-124: chromosome synapsis was not examined in the mutant. In this context, Line 242-244 explains the chromatin defects in the mutants, but there is no clear characterization.</p></disp-quote><p>We acknowledge lack of this evidence; however characterization of chromatin defects and chromosome synapsis is not the focus of the paper. We provided a more precise characterization of the meiotic arrest by γH2AX staining that we included in Figure 1—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>7. Figure 2—figure supplement 2 should be described in the order of the explanation.</p></disp-quote><p>We thank the reviewer for pointing this out. We moved this figure to Figure 6—figure supplement 1 as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>8. Line 155-158: The Pink1 single mutants should be characterized before examining the double mutants. In flies, PINK1 is required for spermatogenesis (Clark et al., Nature 2006: PMID 16672981). Thus, it is interesting if PINK1 is not required for spermatogenesis in mice. Results of fertility tests should be provided here as well.</p></disp-quote><p>We provided additional histological in data on single <italic>Pink1</italic> and <italic>Pgam5</italic> KO in Figure 3. Moreover, we performed a series of novel AIF1 staining confirming that <italic>Pink1-/-</italic> testis, as well as <italic>Pgam5/-</italic> have normal production of spermatids in sharp contrast with <italic>Parl-/-</italic> which show complete premeiotic maturation arrest. We included these data in Figure 3 – supplement 1. Moreover we specify that <italic>Pink1-/-</italic> mice are fertile as also indicated in the JAX website: https://www.jax.org/strain/017946<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/017946">;</ext-link> in fact <italic>Pink1-/-</italic> mice as well as <italic>Pgam5-/-</italic> and <italic>Ttc19-/-</italic> were also bred as homozygous mutant. Moreover, the phenotype of <italic>PINK1-/-</italic> flies is very different and much more severe than <italic>Pink1-/-</italic> mice which have barely any detectable phenotype and normal lifespan.</p><disp-quote content-type="editor-comment"><p>9. Figure 4D is not possible to interpret. Please show the wild-type and mutant data separately and explain in a way general audiences can understand.</p></disp-quote><p>This figure does not show WT and mutant data altogether so it cannot be split as suggested. It is an illustrative trace of one experiment to graphically illustrate to readers interested in bioenergetics how the high-resolution respirometry was performed, and to reassure of the validity of this delicate experiment. We try to improve this explanation in the text and legend.</p><disp-quote content-type="editor-comment"><p>10. The Discussion section is disorganized and hard to read.</p></disp-quote><p>We thank the reviewer for pointing this out. We substantially rewrote the discussion trying to organize it better and improve readability. To illustrate better the complex pathways that are involved we included a cartoon in Figure 7.</p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors have addressed my primary concerns by providing quantitation of immunofluorescence microscopy and EM images, as well as additional controls and explanations. Functional infertility assessed by co-housing of mutant males with wild type females, which is an important addition to the report of azoospermia in describing an infertility phenotype, is now described at the beginning of the Results section. The paper makes a strong case for ferroptosis as a mechanism for germ cell death in Parl mutants and represents an advance in the fields of male fertility and mitochondrial function. There are two remaining points that I think should be acknowledged in the Discussion section:</p><p>1) I agree with reviewer 2 that analysis of stage-specific germ cells is important for the conclusions. In their rebuttal, the authors argue that deletion of Parl in all cells in the germline (whole body) knockout makes this concern irrelevant; this is not true because Parl is likely functioning differently across different germ cell types, making differing cell compositions a potential artifact in bulk assays. In addition, in a whole-body knockout there may be cell non-autonomous effects from testis somatic cells. The data from 4-week testes referred to in the rebuttal will not address the cell composition issue because by 4 weeks (28 days) there will be advanced round spermatids in control testes, meaning that cell compositions will differ between KO and control.</p><p>Taking all the data together, I think that the immunofluorescence data strongly supports a cell autonomous effect of Parl knockout in spermatocytes as the authors suggest. However, I think that they should acknowledge the possible issues related to mixed cell populations and somatic cell effects in the Discussion section.</p></disp-quote><p>We added this caveat at the end of the first paragraph of the discussion.</p><disp-quote content-type="editor-comment"><p>2) Similarly, the data as a whole strongly supports ferroptosis as a mechanism for germ cell death in the Parl KO, but it is difficult to fully exclude non-ferroptotic 'accidental' necrosis. This should also be acknowledged in the Discussion section.</p></disp-quote><p>We added in the discussion that it is impossible to demonstrate the presence of accidental necrosis in vivo since no specific biomarker is currently available for accidental necrosis. However, whether accidental necrosis contributes in part to the cell death phenotype, this would not change the conclusions of the study.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>In this revision, I appreciate the authors' massive efforts to address my previous concerns, but I do not think my main concerns were not effectively addressed. The study provided several indirect evidence of germ cell ferroptosis, but I do not think the results firmly established the occurrence of germ cell ferroptosis. In general, perturbations in mitochondria dynamics could be expected to disrupt spermatogenesis. It would be necessary to clearly define germ-cell ferroptosis to explain the specific phenotype of the PARL mutants. Overall, I appreciate the potential impact; but I am not fully convinced by the main conclusion reported in this study yet.</p><p>1. The main issue is that the manuscript, including some of the revised parts, was not clearly written. I still do not understand many parts. Now, the abstract, results, and discussion are hard to read. The authors should clarify the contents and ask a professional editor to clarify the language. I am sorry that it took time to review the revised manuscript.</p></disp-quote><p>We acknowledge that paper may be in some parts hard to read given complexity of the topic, and also the massive amount of data that have been added to address the reviewer’s concerns. We have again modified both abstract and discussion with the hope of improving the readability of the content. Upon request of the reviewer, we previously added a cartoon illustrating the key elements of the paper (Figure 7). At this stage, in absence of more precise indications, we cannot further address this point. If the paper is accepted, our English native speaker coauthors will work with the editorial office to perform a thorough style improvement and proofreading before publication.</p><disp-quote content-type="editor-comment"><p>2. Ferroptosis is not reported in mammalian germ cells. However, the revised manuscript only indirectly supports the possibility of germ-cell ferroptosis in the mutants. The authors did not address my previous concern: the authors should clarify the definitions of ferroptosis in the field and demonstrate definitive evidence of germ-cell ferroptosis in mammals. Again, P53 is not the only marker for ferroptosis. Please add a paragraph summarizing the definitions of ferroptosis in mammals and explain how observation here fulfills these criteria.</p></disp-quote><p>In our previous revision we have already addressed this question and explained the definition of ferroptosis and how our observations fulfil these criteria. We highlighted further in this revised version that ferroptosis is a caspase independent type of regulated cell death defined by uncontrolled lipid peroxidation. This is demonstrated by a dramatic increase in 4-HNE signal in degenerating PARL-deficient spermatocytes. Moreover, PARL-deficient spermatocytes have a dramatic cell-specific expression defect of the major ferroptosis inhibitory enzyme GPX4. Genetic or chemical inactivation of this enzyme alone is sufficient to induce ferroptosis in a variety of models both in vitro and in vivo. Finally, we have shown that additional established biomarkers of ferroptosis such Tfr1 and p53 consistently increase in PARL-deficient degenerating spermatocytes, providing unambiguous evidence of ferroptosis in PARL-deficient spermatocytes.</p><disp-quote content-type="editor-comment"><p>3. The mutant testes were depleted with late germ cells, and the composition of germ cells was apparently different between the wild-type and mutant testes. The issues are that the mutant testes are enriched with spermatogonia, and the controls are enriched with the late stages of spermatogenesis. I appreciate the authors have done many analyses using the whole testis in this revision. However, they did not address this main point. I understand it can be challenging to isolate germ cells of specific stages from wild-type and mutant testes. At least, the authors should confirm the main conclusions using analyses of juvenile testes (in which cellular composition is not changed yet). For example, at least the reduction of CoQ (Figure 5A) should be examined to solidify the main conclusion.</p></disp-quote><p>We have already addressed the issue of the different cell type composition in WT and <italic>Parl-/-</italic> testis in the previous revision by repeating all experiments with quantitative immunofluorescence in specific germ cell populations (e.g. SCP-1-positive cells). This alternative approach to germ cell isolation has been deemed appropriate by the Editors to address the issue of different cellular composition between WT and PARL-deficient testis. Furthermore, this method allows us to visualize and quantify the expression of relevant markers within the intact and unperturbed tissue context avoiding the experimental biases associated with the artificial manipulations for isolating germ cells (PMID: 30149006). The quantitative immunofluorescence data have already been included in 7 supplementary figures added to the previous revised version of our manuscript. All these experiments have confirmed and strengthened our original conclusions. Therefore, we believe that purification of germ cells would not add any relevant scientific information. We also think that it would be ethically not acceptable violating the 3Rs rule of animal experimentation.</p><p>Repeating the analysis in juvenile testis in which cellular composition is not changed by PARL deficiency is not necessary in our opinion since we already addressed the question of cell type composition as explained above as well as in our previous submission. Moreover, based on preliminary data in our possession, the analysis of earlier time points would not be informative in that context since the cell composition is changed very early on, well before the presence of germ cell degeneration. Ongoing investigations on the early molecular mechanisms underlying the PARL-deficient phenotype will be part of an independent study which goes beyond the scope of this publication.</p><disp-quote content-type="editor-comment"><p>4. I suggested that &quot;results of fertility tests should be provided.&quot;At least, please show how many mice were examined for what duration.</p></disp-quote><p>We have checked this more carefully and concluded that it is impossible to provide meaningful information on this point, since mice acquired full fertility after 6-8 weeks of life but <italic>Parl-/-</italic> mice develop neurological abnormalities by the age of 6 weeks and die by the age of 7 weeks. Therefore, although we know for sure that <italic>Parl-/-</italic> mice are not able to fecundate WT females, we cannot use this argument to. Therefore, we deleted this sentence from the manuscript. The same holds true for PARL double and triple KO (Parl-/-/Pink1-/-); Parl and Pgam5 (Parl-/-/Pgam5-/-); Pink1 and Pgam5 (Pink1-/-/Pgam5-/-); and Parl, Pink1, and Pgam5 combined (Parl-/-/Pink1-/-/Pgam5-/-). We modified Figure 3 accordingly.</p><p>Nevertheless, our data clearly show that <italic>Parl-/-</italic> mice are indisputably sterile due to total lack of sperm production caused by completely arrested spermatogenesis and consequent azoospermia. This has been clearly documented through our detailed histological analysis and AIF1 staining, as specified in the previous revision. In conclusion, we believe that fertility tests are superfluous since we have demonstrated that no spermatozoa are produced in any PARL deficient mouse line, which are therefore necessarily infertile.</p><disp-quote content-type="editor-comment"><p>5. Figure 1—figure supplement 1: PARL deficiency should be confirmed in mutant Leydig cells. In this case, I understand that there is no PARL antibody to confirm. This caveat can be noted.</p></disp-quote><p>We specified this caveat in the manuscript.</p><disp-quote content-type="editor-comment"><p>6. Figure 4D is still not possible to interpret. Please clearly explain what this means in detail.</p></disp-quote><p>We are confused by this repeated request, since a very detailed explanation has already been specified in the legend, in the text, and in the rebuttal letter of the previous submission. This figure is an illustrative trace, as provided by the Oroboros 2K high resolution respirometer, of a high resolution respirometry protocol that has been used in the study. The Oroboros 2K respirometer is currently the state-of-the-art instrument to perform the oxygen consumption analysis. This should be especially interesting for scientists interested in mitochondrial bioenergetics since we are not aware of previous studies/methods to perform high-resolution respirometry in testis mitochondria. We believe it is important to publish at least one illustrative trace of similar experiments in order to explain visually the experiment and build solid confidence in the results. We believe that a full course on high-resolution respirometry is out of scope in the paper. For further informations on high resolution respirometry it is possible to find extensive literature elsewhere (some examples: PMID: 18536644, PMID: 27008969, PMID: 32200800) and in the BIOBLAST website https://www.bioblast.at/index.php/MitoPedia:_SUIT</p><disp-quote content-type="editor-comment"><p>Also, I found a weird mark in the middle of the panel.</p></disp-quote><p>We erased the Oroboros 2k symbol that was automatically attached by the software DATLAB.</p><disp-quote content-type="editor-comment"><p>7. New Figure 6C: GPX4 expression appears to be reduced in various cells in Parl-/- testes, but I do not see any cell-type specific reduction in spermatocytes. Is GPX4 highly expressed in other stages in the mutants?</p></disp-quote><p>We are puzzled by this comment. As explained in the text, Fig6C and its insets show exactly the opposite: a clearly reduced expression of GPX4 expression in <italic>Parl-/-</italic> spermatocytes but normal expression in Leydig cells. To corroborate these finding, we added in the previous submission ad hoc experiments with quantitative immunofluorescence showing a dramatic reduction of GPX4 in SCP-1-positive spermatocytes but not in Sertoli cells.</p></body></sub-article></article>